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ABSTRACT  
   
The purpose of this study was to examine the association between characteristics of the 
symptomatology change curve (i.e., initial symptomatology, rate of change, curvature) 
and final treatment outcome. The sample consisted of community clients (N = 492) seen 
by 204 student therapists at a training clinic. A multilevel approach to account for 
therapist effects was followed. Linear, quadratic, and cubic trajectories of anxiety and 
depression symptomatology, as assessed by the Shorter Psychotherapy and Counseling 
Evaluation (sPaCE; Halstead, Leach, & Rust, 2007), were estimated. The multilevel 
quadratic trajectory best fit the data and depicted a descending curve (partial “U”-
shaped). The quadratic growth parameters (intercept, slope, quadratic) were then used as 
predictors of both symptom change and reliable improvement in general symptomatology 
(pre- to post-treatment), as assessed by the Outcome Questionnaire-45.2 (OQ-45.2; 
Lambert, Hansen, Umpress, Lunen, Okiishi et al., 1996). The quadratic growth 
parameters of depression and anxiety showed predictive power for both symptom change 
and reliable improvement in general symptomatology. Patterns for two different 
successful outcomes (1-change in general symptomatology and 2-reliable improvement) 
were identified. For symptom change, successful outcomes followed a pattern of low 
initial levels of depression and anxiety, high initial rates of change (slope), and high 
(flattening after initial drop) curvature, and the pattern applied to both within- and 
between-therapist levels. For reliable improvement at within-therapist level, successful 
outcomes followed a pattern of high initial rate of change (slope) and high curvature.  For 
reliable improvement at between-therapist level, successful outcomes were associated 
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with a pattern of low initial levels of depression and anxiety. Implications for clinical 
practice are discussed. 
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CHAPTER I 
Introduction 
Studying treatment outcome and predicting the efficacy of psychotherapy 
treatments were major foci of psychotherapy research (see e.g., Castonguay, 2013; 
Gomes-Schwartz, 1978; Sandell, 1988). Over time, this approach evolved, and the focus 
transitioned from the study of outcome to the study of the process of therapy. Process 
research helps us understand not only if symptoms change but how they change during 
the course of the treatment (Kazdin, 2007, 2008; Pachankis & Goldfried, 2007). 
While there have been a good number of examinations of the process of 
therapy over time with respect to the behavior of the clients, such as emotional 
reactivity, negative affect, or attachment, to name a few (see e.g., Scharf & 
Bartholomew, 1994; Staebler, Gebhard, Barnett, & Renneberg, 2009; Windsor & 
Anstey, 2010), there have been relatively few examining trajectories of 
symptomology (shape of the change curve) and its relation to final treatment 
outcome (e.g., levels of symptom change between pre- and post-treatment). This 
association is important, as it can help clinicians elucidate what patterns are related 
to successful treatment—the latter being an ultimate goal in psychotherapy. Patterns 
depict ‘when’ (timing) and ‘how much’ change (magnitude) is happening (Owen, 
Adelson, Budge, Wampold, Kopta, Minami, et al., 2015), so clinicians can modify 
the therapeutic approach and obtain better results with clients (Hayes, Laurenceau, 
Feldman, Strauss, & Cardaciotto, 2007; Kopta, Lueger, Saunders, & Howard, 1999; 
Laurenceau, Hayes, & Feldman, 2007; Pachankis & Goldfried, 2007).  
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Despite the importance of identifying patterns of successful outcomes in 
psychotherapy, current research has not provided clear information about trajectories 
associated with good outcome. Diverse shapes of trajectories have been found, and 
individual characteristics of the trajectory (e.g., early change) have been associated 
with final treatment outcome (e.g., Lutz et al., 2014; Stulz, Lutz, Leach, Lucock, & 
Barkham, 2007) rather than all features of the change curve (e.g., initial level of 
symptoms, rate of change, and variability in rate of change). Moreover, statistical 
dependency of data (data of subjects of the same group being more similar compared 
to data of subjects from other groups) has been disregarded, as therapist effects on 
outcomes have not been taken into account, casting doubts on inferences. These 
aspects have not facilitated the identification of clear patterns of successful 
treatment, and thus represent an important area of research.  
The Shape of Symptomatology Change 
The general goal of process research is to describe the mechanisms that 
foster change and reduction in psychological symptoms (Pachankis & Goldfried, 
2007). Laurenceau and colleagues (2007) assert that through process research we 
can address three important questions to uncover those mechanisms: “what is the 
shape of change?”, “for whom and under what conditions does change occur?”, and 
“why is change occurring?” (p. 684). The purpose of this study was to address the 
first question (the shape of change) and to find associations with successful and 
unsuccessful treatment. 
Why the shape matters? Examining the shape of symptomatology change 
is one way to discern how clients change (Hayes et al., 2007; Laurenceau et al., 
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2007; Pachankis & Goldfried, 2007). By examining the shape, we can answer 
several questions including: (1) whether or not change occurs at a steady rate (i.e., 
how fast or slow change is), (2) when the ‘bulk’ of change occurs (at the beginning, 
middle, or end of the treatment), (3) what is an optimal number of sessions, and (4) 
how does the shape vary across individuals (see e.g., Laurenceau et al., 2007). These 
aspects will be explained next. 
Understanding the rate of change over time. The rate of change (also called 
‘slope’) describes how fast or slow symptoms improve (or deteriorate). Although 
experts agree that change is not constant (see e.g., Balbi & Nardone, 2015; Carroll, 
2003; Hayes et al., 2007), there are still several questions to examine. Some of them 
include: “is fast change always desirable?”, “when does the ‘fastest’ change occur?”, 
or “what rate of change is related to final outcome?”  
Identifying when most change takes place. Literature suggests that most 
change takes place early (first sessions) in the treatment (Grilo et al., 2001; Ilardi et 
al., 1994; Penava et al., 1998). Experts have associated early change to final 
outcome (e.g., Lutz et al., 2014; Stulz et al., 2007), yet, there is still no agreement 
about what ‘early response’ is (Haas, Hill, Lambert, & Morrell, 2002). In addition, 
‘sudden gains’ as defined by a remarkable reduction in symptoms from one session 
to another one (Tang & DeRubeis, 1999; Tang, Luborsky, & Andrusyna, 2002) 
represent another phenomenon related to significant change, and it has been 
associated with long-term outcomes (Tang & DeRubeis, 1999). Examining the shape 
of the curve helps determine whether or not early /sudden gains are occurring, when 
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they occur, and if they are related to successful treatment as defined by a reduction 
in symptoms. 
Determining an optimal number of sessions. A frequent question in 
psychotherapy is, “How much is enough?” (Kopta, 2003; p. 728) or how many 
sessions are needed to obtain meaningful change. Howard and colleagues (1986) 
introduced the “dose-effect” association in psychotherapy (dose = number of 
sessions; effect = percentage of clients improved) and found that “the more 
psychotherapy, the greater the probability of improvement, with diminishing returns 
[obtained] at higher doses” (Kopta et al., 1994; p. 1009). Multiple “dose-effect” 
studies have been carried out to determine how much is enough (see e.g., Barkham 
et al., 2006; Dekker et al., 2005; Kadera, Lambert, & Andrews 1996; Lutz, Lowry, 
Kopta, Einstein, & Howard, 2001). The shape of the change curve (time versus 
symptomatology level) is intrinsically associated with the dose-effect curve (number 
of sessions versus percent improved), as both involve a deceleration of symptoms 
over time. 
Understanding variability across individuals. Responses to treatment can 
widely vary across clients as they don’t follow the same trajectory. Examining 
individual trajectories has helped identify distinctive subtypes or classes (e.g., rapid 
or early responders, non-responders, late responders, or gradual responders) and 
classify individuals (see e.g., Owen, Adelson, Budge, Wampold, Kopta, et al., 2015; 
Taylor & McLean, 1993; Thibodeau et al., 2014). The examination of different 
shapes allows for an understanding of how people vary from the average trajectory 
and how individual trajectories that share similarities are aggregated in subgroups 
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(see e.g., Owen, Drinane, Idigo, & Valentine, 2015; Taylor & McLean, 1993; 
Thibodeau et al., 2014).  
Types of Symptomatology Trajectories. Singer and Willett (2003) describe 
longitudinal change as an increase or decrease of an outcome over time. In 
psychotherapy, outcomes are typically measured by levels of psychological distress 
(also called symptomatology). General psychological distress can be defined as “a 
state of emotional suffering” characterized by psychological, behavioral, or physical 
human responses (Drapeau, Marchand, & Beaulieu-Prévost, 2011, p.105). Specific 
psychological distress (e.g., depression) is related to the “presence or absence of 
specific symptoms,” mostly associated with DSM classifications (Bogat, von Eye, & 
Bergman, p. 799). As such, high symptomatology corresponds to higher levels of 
distress or psychopathology, and a reduction of symptomatology at any point in time 
is considered therapeutic improvement (Brodsky, 1980).  
 In psychotherapy, it is expected that trajectories of psychological distress 
depict a ‘downward’ path over time, showing symptom improvement. These 
trajectories are typically called “decay” or “decline curves” rather than “growth 
curves” (Barkham, Stiles, & Shapiro, 1993). Individual change trajectories depict 
within-person change over time—outcome measure versus time (Singer & Willett, 
2003). An average change trajectory, conversely, is an aggregated trajectory across 
all clients, which shows “everyone’s changes” in one single curve. It can be derived 
from the “curve of the averages” or the “average of the curves” (p. 225). Average 
trajectories might differ from individual trajectories, but estimating them brings 
important benefits such as enabling group-level analyses (Singer & Willett, 2003).  
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The shape of average change trajectories in psychotherapy has been 
examined in past studies, and multiple shapes have been identified including linear 
and non-linear trajectories (quadratic or cubic). Linear trajectories (depicting 
constant rate of change over time) are infrequent in psychotherapy research, but a 
few studies have identified linear trends at subgroup or sample level (e.g., Nishith, 
Resick, & Griffin, 2002; Thompson, Thompson, Gallagher-Thompson, & Alto, 
1995).  
Researchers have found more support for curvilinear trajectories, in specific, 
for quadratic trajectories (e.g., Clapp et al., 2013; Forand & DeRubeis, 2013; 
Wright, Hallquist, Swartz, Frank, & Cyranowski, 2014). A quadratic trajectory 
involves “change in the rate of change” (Heck, Thomas, & Tabata, 2014; p. 187) or 
symptoms that improve fast and then slow. In a quadratic curve, the improvement or 
worsening of symptoms accelerates or decelerates, and thus, shows a variation in the 
steepness of the curve at different points of time. Further, a few studies (e.g., 
Vermote et al., 2009) found cubic trajectories of symptomatology change. These 
trajectories have an “S-shape” and present two points of inflection (bends) on the 
curve (Newsom, 2015), representing ‘slow-fast-slow’ improvement. In sum, 
although the shape of symptoms change has been examined, multiple shapes have 
been identified, exemplifying the complexity of the study of symptomatology 
change. 
Statement of the Problem 
Although there have been studies of the symptomatology change trajectory, 
most studies have focused only on the ‘shape’ of the trajectory (symptom levels vs 
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time), but not on the association with final outcome (e.g., Cannon, Warren, Nelson, 
& Burlingame, 2010; Rasmus, Buckley, & Starkey, 2007; Sunderland, Wong, 
Hilvert-Bruce, & Andrews, 2014). Also, multiple shapes (linear, quadratic, cubic) 
have been found, making it hard to associate trajectories with outcome. 
A few studies examined some associations between trajectories and outcome, 
especially for the trajectory of early change (see e.g., Lutz, Stulz, & Köck, 2009; 
Stulz, Lutz, Leach, Lucock, & Barkham, 2007), but no clear patterns for the entire 
trajectory that ecompasses all the characteristics of the curve (e.g., initial 
symptomatology, rate of change, change in the rate of change) have been found. It 
should be noticed that the studies found associations between trajectory and outcome 
based on subgroups (latent classes) extracted from the overall sample of subjects. 
While there are some advantages to studying subgroups, subgroups lose the power 
of aggregated data and inferences about outcome can be done only at subgroup level. 
Lack of accounting for therapist effects in the analysis was an additional 
issue with these designs. Clients are nested with therapists, affecting the 
independence of data, which represents an issue when predicting outcome. 
Addressing therapist effects and the multilevel structure of psychotherapy data 
(clients nested within therapist) is essential to avoid overstating precision and 
potentially biased results (Falkenström et al., 2013; Owen, Drinane, Idigo, & 
Valentine, 2015; Tasca, Illing, Joyce, & Ogrodniczuk, 2009). In sum, there are 
multiple areas to address (1-examine all attributes of the curve, 2- use aggregated 
data rather than subgroups, 3-consider therapist effects) in order to understand how 
the trajectory predicts final outcome and the patterns for successful treatment. 
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 Purpose of the Study  
Given the importance of studying trajectories of symptomatology change and 
the lack of clear results in the identification of patterns of successful treatment, my 
purpose with this research was to study the shape of symptomatology change and to 
find associations with successful and unsuccessful treatment. I also aimed to address 
aspects disregarded in past research (e.g., patterns derived from aggregated data, 
therapist effects). As such, I intended to answer the following questions: (1) is there 
a general pattern for treatment?, and (2) how do characteristics of this pattern predict 
successful treatment? Next, I will review the literature and will present 
comprehensive information and detailed hypotheses about these patterns and how 
they predict outcome.  
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CHAPTER II 
Review of the Literature 
Patterns of Change and Symptomatology Types 
Outcome and symptomatology can be assessed with instruments measuring 
general symptomatology (general levels of distress) or specific symptomatology (e.g., 
mood disorders including anxiety and depression, substance use, personality disorders).  
Two of the most common presenting problems in psychotherapy are depression and 
anxiety. The prevalence of depression in the U.S. population compared to other 
psychological problems is significant. Approximately 4% to 10% of adults suffer from 
depression and up to 17% experience depression in their lifespan, with 7% reporting a 
major episode in the past two months (Center for Disease Control, 2013; Kessler, 1994; 
Regier et al., 1993). The prevalence of anxiety in a lifetime is approximately 15% (Center 
for Disease Control, 2013) with some subgroups (e.g., women) showing higher 
prevalence. Further, depression and anxiety show substantial comorbidity (Hecht, Von 
Zerssen, Krieg, Pössl, & Wittchen, 1989), and diagnosing is frequently complex, given 
the overlap of symptoms. To better understand different trajectories, experts have studied 
patterns of change for general and specific symptomatology, including the most common 
presenting problems (depression and anxiety). 
Patterns of change in general symptomatology. Multiple longitudinal patterns 
(including linear, quadratic, and cubic) have been found using instruments to assesses 
general symptomatology. For instance, Lambert, Hansen, and Finch (2001) examined 
change trajectories of 11,942 patients with diverse presenting problems (i.e., adjustment 
disorders, mood disorders, and anxiety) and varying treatment lengths (at least 3 
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sessions). General symptomatology was measured using the Outcome Questionnaire-45.2 
(OQ-45.2; Lambert, Hansen, Umpress, Lunen, Okiishi et al., 1996). Lambert and 
colleagues modeled growth curves using Hierarchical Linear Modeling (HLM) and found 
50 subgroups of subjects (bands) based on initial level of symptoms (ranging from 0 to 
180). They found that the trends of change trajectories were mostly linear. However, it is 
important to note that the subgroups were similar in terms of level of initial 
symptomatology and each subgroup represented about 2% of the entire sample. The 
average change trajectory was not analyzed. 
Also, Rasmus, Buckley, and Starkey (2007) examined 33 adult outpatient clients 
with mood disorders, adjustment issues, and relational problems treated by 19 counselors 
over the course of approximately 10 sessions. Rasmus and colleagues assessed general 
symptomatology using the Outcome Questionnaire-45.2 (OQ-45.2; Lambert, et al., 1996) 
at session 1, 4, 7 and 10, and they carried out curve fitting analyses with aggregated 
(average) data. The research team found that the best fitting curve depicted a negatively 
accelerated, quadratic trajectory of change over time. 
In addition, Cannon and colleagues (2010) examined trajectories of change of 
2,715 youth patients (mean age of 14) with mood disorders, substance use, and ADHD, 
among other presenting problems. Outcome and levels of general symptomatology were 
assessed with the Youth- Outcome Questionnaire (Y-OQ-2.01; Burlingame, Wells, & 
Lambert, 1996; Burlingame, Wells, Lambert, & Cox, 2004). Even though the treatment 
was 18 weeks, the average number of outcome measures obtained was 5, and average 
time intervals between assessments ranged from 2.6 to 8.9 weeks. Cannon and colleagues 
used a Multilevel Model (MLM) approach to model change trajectories with Y-OQ 
  11 
scores and time as variables (therapists effects were not part of the MLM design). The 
authors found support for curvilinear trajectories with rates of change that became 
successively slower over the course of the treatment. 
Finally, Vermote and colleagues (2009) used a naturalistic design to study 
symptomatology in a sample of 70 adult inpatient clients with personality disorders and 
with a length of stay ranging from 1.5 to 13 months. The treatment program encompassed 
group therapy, individual therapy, non-verbal therapy (music therapy) and psychiatric 
consultation. A global score of symptoms (GSS) was obtained from a battery of 
instruments which included general symptomatology scales such as the Symptom 
Checklist (SCL-90; Arrindell & Ettema, 1986), as well as specific instruments like the 
Beck Depression Inventory (BDI; Bouman, Luteijn, Albersnagel, & Van der Ploeg, 
1985). Measures were obtained at intake and 3-month intervals. Using growth curve 
analysis, the researchers found that the overall trajectory of symptoms followed a cubic 
trend, with little improvement in the beginning, followed by high improvement in the 
middle and stable improvement at the end. 
Pattern of change in depression. Patterns of change in clients with depression 
have been analyzed, and the majority of the studies found support for curvilinear 
trajectories. For instance Sunderland, Wong, Bruce, and Andrews (2012) examined the 
trajectory of symptomatology change in a sample of 663 adult patients with depression 
and anxiety. Services were provided through 6 internet-based CBT sessions (lessons), 
and outcome was primarily assessed with the Kessler-10 Psychological Distress Scale 
(K10; Kessler et al., 2002) before each online lesson. The K10 global measure is based 
on anxiety and depression items. Using Growth Mixture Modeling (GMM), the authors 
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found that a quadratic model provided the best fit, suggesting that the decrease of 
symptoms follows a curvilinear trajectory with the most change happening in the first 
few sessions. 
In addition, Clapp and colleagues (2013) examined the change trajectory of a 
sample of 1,084 adult psychiatric inpatients with various diagnoses including depression, 
bipolar, psychotic, and substance use disorders. Outcome focused on depressive 
symptoms using the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) 
at admission and then bi-weekly for the duration of the stay (duration was not specified). 
Clapp and colleagues used Latent Growth Curve (LGC) analysis and found that a 
quadratic model provided a better fit to the data compared to the linear model, and that 
symptom improvement occurred in the first week of admission. 
Using the Beck Depression Inventory-II (BDI-II; Beck, Steer & Brown, 1996) 
and the Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988), Forand and 
DeRubeis (2013) examined depression symptomatology in 180 clients over the course of 
16 weeks. The researchers used Hierarchical Linear Modeling (HLM) and found support 
for a quadratic model. They also found that levels of anxiety at intake predicted early 
rapid change in depression symptomatology.   
Furthermore, Wright and colleagues (2014) examined the symptoms of 78 adult 
patients with anxiety and depression treated with a multimodal approach in 
psychotherapy (e.g., individual therapy, group therapy, medication, and psychoeducation) 
over the course of 16 sessions. They measured symptomatology using the Hamilton 
Rating Scale for Depression–Core Symptoms (HRSD-CS; Hamilton, 1960) at each 
session and found that symptoms depicted a quadratic trajectory with most pronounced 
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declines occurring at the beginning of the treatment, followed by less pronounced decline 
later on. Taken together, these studies supported that a quadratic trajectory of change 
(symptoms that vary in the rate of change) best describe the progression of symptoms 
over time. 
Patterns of change in anxiety. Longitudinal studies of anxiety have shown 
diverse patterns of symptom change. For instance, Stanley and colleagues (1996) studied 
70 adult patients with panic disorder over the course of 10 sessions. The team used 
anxiety instruments such as the State-Trait Anxiety Measure (STAI; Spielberger, 
Gorsuch, & Lushene, 1970), and the design included a multivariate analysis 
(MANOVA). Stanley and colleagues found fast change at different periods of time 
depending on the intervention type (a greater reductions in the first half of the treatment 
with relaxation training and faster reductions in the second part of the treatment with 
cognitive therapy). 
In a review of research, Hayes and colleagues (2007) studied the trajectory of 
several anxiety studies including Heimberg and Becker’s (2002), Nishith, Resick, and 
Griffin’s (2002), and Gilboa-Schechtman and Foa’s (2001). Hayes found that these 
trajectories shared discontinuous patterns, with a peak of heightened symptoms (intended 
to increase arousal and facilitate change) preceding a decrease of symptomatology. 
However, the diagnoses were PTSD or specific phobias (social phobia), and the 
instruments were specific for PTSD, such as the Clinician-Administered PTSD Scale 
(CAPS; Blake et al., 1990), the PTSD Symptom Scale (PSS; Foa, Riggs, Dancu, & 
Rothbaum, 1993). 
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Furthermore, Hedman and colleagues (2013) studied a sample of 81 clients with 
severe health anxiety (hypochondriasis) who received Internet-based CBT over 12 weeks. 
Outcome was measured with the Health Anxiety Inventory (HAI; Salkovskis, Rimes, 
Warwick, & Clark, 2002). Using linear and logistic regression, Hedman and colleagues 
found that higher baseline anxiety (e.g., intake) was associated with lower chances of 
improvement, and years with severe health anxiety were not significantly associated with 
outcome. 
In sum, longitudinal analyses of general symptomatology and anxiety showed 
diverse patterns. In contrast, most analyses of depression (Clapp et al. 2013; Sunderland 
et al., 2012) suggested that quadratic curves best represent the shape of the trajectory in 
most cases. Results also showed that most change occurred early in the treatment (first 
few weeks of therapy). Findings were similar for different ages (youth and adults) and 
treatment formats (inpatient/ outpatient; in person/ online).   
Associations Between Trajectory and Final Outcome 
The shape of the trajectory in psychotherapy has been broadly examined, and 
several findings support a quadratic shape, but little has been said about how the 
trajectory relates to final treatment outcome: how the patterns of successful outcome look 
like? Considering that one of the main objectives in psychotherapy research is to predict 
final outcome (Castonguay, 2013; Gomes-Schwartz, 1978; Sandell, 1988) and that there 
is a current emphasis on associating process to outcome (Greenberg, 2015; Hardy & 
Llewelyn, 2014), then examining the association between the shape and final treatment 
outcomes becomes relevant.  
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Few studies have attempted to examine this association. One of those studies was 
conducted by Thompson and colleagues (1995). They used a regression line to fit 
symptom levels to a longitudinal trajectory and calculated levels of non-linearity (shifts 
in the trajectory). Thompson and colleagues found a positive correlation between overall 
levels of non-linearity and recovery rate. Although this was one of the first studies that 
attempted to link shape and outcome, the examination of shapes was done within 
subgroups (recovered versus non-recovered) rather than examining the whole sample, 
and the goal was not to predict final outcome based on the shape of the trajectory.  
Another study was conducted by Stulz and colleagues (2007), who examined the 
association between patterns of early change (first 6 weeks of therapy) and final outcome 
in a sample of 192 teenage and adult clients who had a treatment duration of 7 to 203 
sessions  provided by 33 therapists. Symptomatology was assessed with the Clinical 
Outcomes in Routine Evaluation (CORE; Cahill et al., 2006). Using GMM, Stulz and 
colleagues analyzed subjects who had at least 3 of the first 6 weeks of treatment, and 
found five distinctive groups or classes of trajectories in those initial 6 weeks (i.e., early 
improvement, low impairment, high impairment, continues, and discontinues).  
Improvement at termination (effect size of change during treatment) was assessed within 
each group by using the reliable change (RC) criterion (e.g., Jacobson & Truax, 1991), 
which compares the change between two measures and determines if change occurred. 
The “early improvement” group showed the highest gain (96% reliably improved) 
compared to other groups such as the “high impairment” group (22% reliably improved).  
Similarly, Lutz and colleagues (2009) conducted a GMM analysis of 162 patients 
with depression during 14 to 23 week. Outcome was measured with the Beck Depression 
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Inventory (BDI; Beck, Steer, & Brown., 1996) at intake, weeks 4, 8, 12, 16 (termination), 
and post treatment (months 6, 12, and 18). The research team found three distinctive  
subgroups or classes of trajectories based on ‘early change’ (first 8 weeks):  (1) Moderate 
to severe depression with moderate early improvement, (2) Moderate to severe 
depression with rapid early improvement, and (3) Mild to moderate depression with 
moderate early improvement. Prediction of final outcome was done by comparing the 
percentage of patients who “reliably improved” after 16 weeks. Lutz and colleagues 
found that 100% of group-2 patients (Moderate to severe depression with rapid early 
improvement) improved after 16 weeks compared to the other groups (69% for group 1 
and 34% for group 3). Lutz and colleagues concluded that ‘rapid early improvement’ was 
associated with good final outcomes. Lutz et al. acknowledged that higher responsiveness 
might have been associated to other factors, such as a higher expectation of receiving 
help. 
Later on, Lutz and colleagues (2014) carried out a similar study with 326 patients 
with panic disorder. They used GMM to model change over the first 4 weeks of 
treatment, and outcome was measured with the Panic Disorder Severity Scale – Self-
Report Version (PDSS-SR; Shear et al., 1997). Lutz and colleagues found four classes of 
trajectories (‘early deterioration,’ ‘medium symptoms -slow change,’ ‘high symptoms- no 
change,’ and ‘early response’). They found that the ‘early response’ group had the 
highest rates of improvement (93%) from intake to termination, and concluded that class 
membership predicted final outcome. Again, this argument was based on percent of 
improvement within the subgroup. 
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In the above studies, the authors concluded that certain patterns of trajectories 
(i.e., rapid early improvement) were associated with positive final outcomes. These 
designs, however, did not address several aspects: (1) the trajectory of the entire 
treatment was not examined but only the first weeks of treatment, (2) the study was done 
by subgroups, losing the power of aggregated date to make inferences, and (3) therapist 
effects were not examined, losing the power of aggregated data to make inferences.  
 Overall, there is limited research about the association between the shape of the 
change trajectory and final outcome. Some studies (i.e., Thompson, Thompson, 
Gallagher-Thompson, & Alto, 1995) used correlation to link shapes of trajectories and 
outcome. Other studies examined the shapes of subgroups and compared percent of 
improvement across subgroups. Also, these studies focused on the shape of ‘early 
change’ rather than the shape of the entire treatment. Moreover, the effect of therapists 
was not included. 
Selecting Outcome Measures  
 To analyze associations between symptomatology trajectories with final outcome, 
two different instruments were needed in the present study: one instrument to measure 
symptoms over time and the other instrument to measure change pre- to post-treatment. 
Several factors were taken into account to select measures. First, longitudinal research 
benefits from the use of brief scales that facilitate administration and scoring (Boswell, 
Kraus, Miller, & Lambert, 2013; Smith, McCarthy, & Anderson, 2000). Second, 
depression showed more clear patterns of change compared to general symptomatology 
or anxiety, so a measure of depression was appropriate to predict final outcome. Third, 
this measure should have adequate predictive power in order to predict final outcome. 
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Fourth, literature shows that depression is significantly correlated with other 
psychopathologies (Gotlib, 1984; Gotlib, Lewinsohn, & Seeley, 1995; Kaufman & 
Charney, 2000; Rohde, Lewinsohn, & Seeley, 1991). 
 The Shorter Psychotherapy and Counseling Evaluation (sPaCE; Halstead, Leach, 
& Rust, 2007) meets several requirements to measure longitudinal symptomatology. The 
sPaCE is a brief (19-item) scale with good psychometric properties and convergent 
validity with the BDI. Also, the sPaCE has good sensitivity to change (Halstead et al., 
2007), relevant to longitudinal research and it has incremental predictive power over 
other brief measures (Jimenez-Arista, Holzapfel, Shanholtz, & Tracey, in press). 
Importantly, the sPaCE was developed to capture two of the most common presenting 
problems in therapy (depression and anxiety). 
 Final outcome (pre- to post-treatment) was measured in this study with the 
Outcome Questionnaire-45.2 (OQ-45.2; Lambert, Hansen, Umpress, Lunen, Okiishi et 
al., 1996), one of the most utilized scales of general symptomatology. Good validity 
(Lambert, et al., 1996; Mueller, Lambert, & Burlingame, 1998; Umphress, Lambert, 
Smart, Barlow, Clouse, & Hensen, 1997) makes this instrument adequate to measure final 
treatment outcome. In order to have relevant criterion variables and validate the results, 
two measures of outcome derived from the OQ-45 were used in this study: (1) change in 
symptoms and (2) reliable improvement. Change in symptoms represents the gain or 
improvement from intake to termination (including small change and big change). 
Reliable improvement represents substantial and significant reduction in symptoms and is 
a recommended way to measure change (see e.g., Speer, 1992; Wise, 2004). 
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Predictors of Final Outcome 
In order to hypothesize about trajectories of successful treatment, it is necessary 
to understand the attributes of the trajectory that can predict successful treatment. 
Trajectories have three main attributes (or latent growth parameters): intercept, slope, and 
quadratic terms (Singer & Willet, 2003). The intercept depicts the level of initial 
symptomatology.  Each individual trajectory has its own intercept representing the 
person’s initial level of symptoms. The intercept for the average curve represents the 
average initial level of symptomatology for the sample. Second, the rate of change of 
symptoms, also identified as the slope, can be downward/negative (improving) or 
upward/positive (deteriorating), and it can be steeper (fast change) or less steep (slow 
change).Third, the quadratic parameter indicates the variability in the rate of change, also 
called curvature. This quadratic terms depicts if the trajectory looks more similar to an 
arch (high curvature) when the rate of change is variable (accelerating and decelerating), 
or more similar to a straight line (low curvature) when the rate of change is more steady, 
with more positive values delineating a “U”-shaped curve (upward) and more negative 
values describing an inverted “U”-shaped trajectory (downward). These three 
characteristics, also called ‘latent growth parameters,’ represent distinctive aspects of the 
curve and can depict a pattern for either successful or unsuccessful treatment based on the 
magnitude and direction of the parameters.  
Next, I review what the literature says in regards to these predictors. First, in 
terms of initial symptomatology (intercept), findings show that clients with more severe 
symptoms at intake (high initial symptomatology) do poorly in therapy. For instance, 
Thibodeau and colleagues (2015) found that initial symptom severity predicted 
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“nonresponder” status after 6 months of treatment in a sample of 821 patients with 
depression evaluated with the Montgomery-Asberg Depression Rating Scale (MDRS). 
Similarly, Taylor and McLean (1993) identified that clients who were severely depressed 
at intake and underwent a 10-week treatment tended to have small gains, and they lost 
those gains after a 3-month follow-up in sample of 155 depression clients assessed by the 
BDI. Conversely, research shows that individuals with lower initial symptoms are 
expected to have better results. For example, in a sample of 104 clients with depression 
as assessed by the BDI, clients with low initial symptomatology responded better to the 
treatment compared to individuals with higher initial symptoms (Allart-van Dam, 
Hosman, Hoogduin & Schaap, 2007). Severe symptomatology is often related to 
cognitive deficits, high substance use, dissociation, poor awareness, or low insight. These 
factors may slow or impair treatment given that they affect an individual’s sense of 
awareness, motivation, or the ability to adhere to and complete the course of therapy 
(Bauer et al., 2007; Regier et al., 1990; Sackeim, 1998; Schwartz, 1998). Altogether, 
findings show that low initial distress (low intercept) is associated with better outcomes, 
and high severity of symptoms (high intercept) is associated with poor outcomes.  
Second, in terms of initial rate of change (slope) as a predictor of outcome, 
studies have repeatedly shown that ‘steeper early slopes’ are associated with good 
therapy outcome. For instance, Lewis, Simons, and Kim (2012) contend that rapid early 
response is essential to overall success, and that targeting readiness to change is 
recommended to maximize treatment outcome. Lewis and colleagues examined a sample 
of clients with depression assessed by the BDI and found that the rate of early change 
predicted treatment outcome, explaining 52% of the variance in response to treatment. In 
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addition, Haas and colleagues (2002) found that clients who presented early improvement 
in the first three weeks of treatment had good final outcomes (lower OQ-45 scores) and 
maintained gains up to two years post-termination (Haas, Hill, Lambert, & Morrell, 
2002). Similarly, researchers examining latent classes found that change occurring in the 
first weeks of therapy was associated with symptom reduction or reliable improvement at 
termination for problems such as depression, anxiety, and panic disorder (e.g., Lutz, 
Hofmann, Rubel, Boswell, Shear et al., 2014; Lutz, Stulz, & Köck, 2009; Stulz, Lutz, 
Leach, Lucock, & Barkham, 2007). Lutz’s and Stulz’s teams examined groups of 
trajectories and found that classes with early rapid change (steeper slopes) had better 
results at the end of the treatment as indicated by change scores or reliable improvement. 
The researchers argue that factors such as readiness to change, motivation, and 
expectancy might be related to early improvement. Another aspect associated with a fast 
initial rate of change is sudden gains, as these gains typically occur early in the treatment 
(Greenfield, Gunthert, & Haaga, 2011). Sudden gains (substantial improvement in 
between two sessions) and first-sessions gains (improvement occurring after session one) 
predicted positive outcome (as conceptualized by higher post-treatment recovery rates) in 
cognitive therapy for depression (Busch, Kanter, Landes, & Kohlenberg, 2006). Busch 
and colleagues explained early improvement as change related to non-specific factors 
mediated by hope, rather than related to specific ingredients. It is important to consider 
that rapid early rate of change has been also associated with number of sessions (total 
dose of treatment), as shorter treatments had faster rates of change, and longer treatment 
had slower rates of change (Baldwin, Berkeljon, Atkins, Olsen, & Nielsen, 2009). In sum, 
rapid early change (more negative, downward steep slopes) has been associated with 
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good final outcome. Factors that were conducive to positive early improvement as 
proposed by the researchers (e.g., readiness to change, motivation, expectancy, and hope) 
might also be contributing to positive final change. 
Lastly, curvature depicts if a trajectory is more round (variable change) or more 
straight (steady change), and it also shows if change accelerates or decelerates. In this 
regard, psychotherapy research has consistently shown that progress does not occur at a 
steady rate and therefore, symptom change is not linear (e.g., Clapp et al., 2013; Hayes et 
al., 2007; Sunderland et al., 2012; Wright et al., 2014), but few studies associating the 
degree of curvature and final outcome were found. In one of the studies, Thompson and 
colleagues (1995) studied linearity (steady change) and non-linearity (non-steady change 
including worsening and improvement shifts) in a sample of clients with depression 
undergoing 16 to 20 psychotherapy sessions. Although the researchers did not directly 
examine curvature, they found that the less linear the trajectory, the higher the recovery 
rates, arguing that unsteady rates of change (less linear) were associated with higher 
improvement. In another study, no association between curvature and final 
symptomatology was identified (Rice, Hagler, & Tonigan, 2014). Given the lack of clear 
findings, our rationale to hypothesize about curvature took into account how the linear 
term (slope) and the quadratic term (curvature) are mathematically related, and that a 
decrease in symptoms is desired. First, we expect a curvilinear trajectory of symptom 
reduction and this implies a quadratic term with a positive sign (partial “U” curvature), 
given that the initial slope (linear term) should be negative for successful treatment. 
Second, since we had hypothesized a rapid initial rate of change in the quadratic curve 
(big initial dip) because substantial drops have typically occurred in the first few sessions 
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(Grilo, Masheb, & Wilson, 2006; Kopta, Howard, Lowry, & Beutler, 1994; Penava, Otto, 
Maki, & Pollack, 1998; Rush, Kovacs, Beck, Weissenburger, & Hollon, 1981; Thase, 
Simons, Cahalane, & McGeary, 1991), a successful non-linear trajectory is possible if, 
after the big dip, the trajectory bends and symptoms continue to decrease at a slower pace 
(decelerating), creating a concave form. Thus, the initial drop and symptoms that level off 
after a certain point imply positive values for the quadratic term with a partial “U”-
shaped trajectory (flattening after initial drop). In sum, given the above information, we 
hypothesize that a pattern of successful treatment will have a low intercept (low initial 
symptomatology), a steep downward negative slope (high initial rate of change), and a 
positive curvature (partial “U”-shaped curve). A comprehensive pattern like this that 
predicts successful treatment (symptom reduction) has not been examined in previous 
studies, and further, a key aspect in psychotherapy research, such as the dependency in 
client-therapist data, has been neglected. 
Methodological Recommendations in Process Research  
To make process research and the examination of symptomatology change over 
time effective, experts have provided a series of recommendations including timing of 
assessments, statistical approaches, and addressing therapist effects. Frequent 
assessments and measuring time in weeks or sessions is advised (Laurenceau et al., 2007; 
Pachankis & Goldfried, 2007; Singer & Willett, 2003). It is known that the frequency of 
measures has an effect on the precision of the results (Cook & Ware, 1983; Laurenceau et 
al., 2007; Schaie, 1986; Schmidt & Teti, 2005). It is important to consider how fast 
change in psychotherapy can occur and design accordingly (Laurenceau et al., 2007).  
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Also, the use of sophisticated methods, emerging methodologies, and state-of the-
art approaches is a new direction in process research. These methods include growth 
mixture modeling (GMM), growth curve modeling, Multilevel Modeling (MLM), and 
dynamical systems modeling (Laurenceau et al., 2007; Pachankis & Goldfried, 2007; 
Wright et al., 2014). These approaches allow for exploring different shapes (e.g., 
quadratic or cubic), examining rates of change over the course of the treatment, and 
identifying subgroups (Laurenceau et al., 2007; Wright et al., 2014).  
Therapist effects (or the proportion of variance in outcome explained by therapist 
differences) occur as clients obtain different results with different therapists (Falkenström 
et al., 2013). Findings show that these effects range from 0% to approximately 10%, and 
the effects are larger for naturalistic or non-randomized clinical trials (non-RCTs) 
compared to RCTs. For instance, Wampold and Brown (2005) found therapist effects of 
5% in a naturalistic study with a sample of 6,146 clients and 581 therapists. Later on, 
Kim, Wampold, and Bolt (2006) examined therapist effects in samples from the National 
Institute of Mental Health Treatment of Depression Collaborative Research Program, and 
they obtained an estimated value of 8%, which was superior to the value of treatment 
effects (0%). Elkin and colleagues (2006) obtained contradictory findings, as they found 
an effect of 0% in the same sample. Wampold and Bolt (2006) explained that this 
difference is due to Elkin’s inappropriate assumptions leading to increased patient 
variance. Additionally, in another naturalistic study, Lutz and colleagues (2007) used a 
three-level growth curve model study and found therapist effects of approximately 8% (of 
total variance) in a sample of 1,198 patients and 60 therapists using the Compass tracking 
system (Howard, Moras, Brill, Martinovich, & Lutz, 1996; Lueger et al., 2001; Lyons, 
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Howard, O’Mahoney, & Lish, 1997). Furthermore, Saxon and Barkham (2012) identified 
an average therapist effect of 6.6 %, and the effect was larger (10%) for more severe 
clients in a naturalistic design with 10,786 clients and 199 therapists. Conversely, no 
therapist effects have been found in several randomized studies (see e.g., Ball et al., 
2007; Goldstein et al., 2010). 
Therapist effects have been found to be relevant, and experts recommend to 
control them for in the design (Falkenström, Markowitz, Jonker, Philips, & Holmqvist, 
2013). Disregarding the effect of therapists brings potential negative consequences, such 
as the increase in Type I errors, which might bias the estimation of treatment effects 
(Falkenström et al., 2013; Owen, Drinane, Idigo, & Valentine, 2015; Tasca, Illing, Joyce, 
& Ogrodniczuk, 2009). Furthermore, experts advocate for controlling for therapists 
regardless of the significance level of the effect (Falkenström et al., 2013). Despite these 
recommendations, therapist effects have not been controlled for in process and outcome 
research examining the shape of the change trajectory, which might compromise the 
validity of past results. 
Present Study 
Examining patterns of symptomatology change (shape of the change trajectory 
over time) contributes to the understanding of the mechanisms of change in 
psychotherapy (Laurenceau et al., 2007). Understanding these patterns and identifying 
the shape of the change trajectory assist clinicians to focus on specific periods of time 
during the treatment (e.g., early, middle, late treatment), discern why progress is 
occurring or not, and explore variables associated with symptom change (Laurenceau et 
al., 2007). This can ultimately help practitioners and scholars design effective 
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interventions and obtain better results with clients (Pachankis and Goldfried, 2007; Kopta 
et al., 1999).  
Given the importance of identifying factors of successful treatment (significant 
reduction in symptoms) in order to obtain better results with clients, my goal was to find 
patterns depicting associations between trajectories of symptomatology change and final 
outcome. These associations can be studied by focusing on characteristics of the 
trajectory (latent growth parameters), as they represent identifiable aspects in the course 
of treatment. Such characteristics encompass: (1) initial level of symptoms, also called 
intercept of the trajectory, (2) rate of change of symptoms, also identified as slope, and 
(3) variability in the rate of change, also called curvature of the trajectory. These three 
distinctive aspects can depict a pattern for either successful (reduction in symptoms) or 
unsuccessful (lack or reduction or increase in symptoms) treatment. As suggested by the 
literature that has individually examined characteristics of the trajectory and the 
associations with successful outcome (see e.g., Lutz et al., 2009, 2014; Stulz et al., 2007; 
Thompson et al., 1995), I expected low initial symptomatology, high initial rate of 
change, and high curvature to predict final outcome as defined by a reduction in 
symptoms.  
Given that two of the most common presenting problems in psychotherapy are 
depression and anxiety, this study focused on examining longitudinal patterns of these 
two problems. As such, I selected the sPaCE instrument (Halstead, Leach, & Rust, 2007) 
to assess longitudinal change given that the sPaCE captures depression and anxiety. This 
instrument is also brief and easy to administer, and it has shown good ability to predict 
general symptomatology. To measure final outcome, I selected the OQ-45 (Lambert, 
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Hansen, Umpress, Lunen, Okiishi et al., 1996), a widely used instrument to assess 
general psychological distress, and selected two criterion variables. I expected the 
characteristics of the curve (growth parameters) to predict successful treatment as defined 
as a reduction of symptoms (any level of symptom change) as well as a reduction of 
symptoms that meets standard cut-offs (e.g., reduction of specific points) representing 
significant change (reliable change). 
I also expected to find support for a curvilinear trajectory, as multiple studies 
have shown that psychotherapy change is not linear (Hayes et al., 2007). Specifically, I 
expected to obtain a descending quadratic, partial “U”-shaped trajectory, as this 
trajectory has been identified in multiple studies. In particular, the quadratic curve has 
found support in trajectories of depression and anxiety, which aligns with the measures I 
obtained with the sPaCE. Further, a quadratic curve had good support for various other 
diagnoses. To substantiate this trajectory, I also tested a linear and cubic trajectory to 
identify which one was superior. 
It is important to note that this study examined patterns over the course of the 
treatment and not only “early change,” as done in other studies. The examination of the 
entire treatment provides a more comprehensive picture of symptom change but so far, no 
study predicting final outcome from the entire change trajectory (intake to termination) 
has been done. It is also important to measure symptoms in short intervals (e.g., every 
session) in order to avoid impacting the precision of the analyses (Cook & Ware, 1983; 
Schaie, 1986; Laurenceau et al., 2007; Schmidt & Teti, 2005). Some previous studies had 
long intervals (up to 9 weeks) in between measures; however, the interval of this study 
was one week in between observations (weekly sessions).  
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From a methodological perspective, past studies of patterns and outcome focused 
on subgroups (latent classes) and compared outcomes across groups. Issues with past 
approaches are related to the methodology and the potential consequences on effect size. 
Classes diffuse the effects as they decrease the variability within subgroups, whereas 
aggregated data can show stronger or clearer associations (Ostroff, 1993). A better 
approach to finding patterns is using the power of regression and involving aggregated 
data rather than subgroups. The design I propose has methodological advantages over 
previous studies for various reasons: 1) we can quantify the influence of predictors on 
outcomes, 2) we can identify the direction of that association (direct or inverse), and 3) 
we can use aggregated data (rather than subgroups or classes) to find clearer associations. 
An additional methodological advantage is the inclusion of therapist effects on final 
outcome. Therapist effects have not been controlled for in previous studies, which can 
increase Type I errors and biased results (Falkenström et al., 2013; Owen, Drinane, Idigo, 
& Valentine, 2015; Tasca, Illing, Joyce, & Ogrodniczuk, 2009). 
Overall, my purpose was determine whether or not the shape of the change 
trajectory predicts final treatment outcome, controlling for therapist effects, testing a 
quadratic trajectory, and using the trajectory parameters as predictors. Based on the 
information presented from the literature, I expect successful treatment to be associated 
with a pattern of low intercept, steep downward slope, and high curvature. As such, I 
present the following hypotheses.  
Hypotheses 
Hi:  There will be a pattern of successful outcome (reduction in symptoms) in terms of  
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general Symptomatology change. The descending partial “U”-shaped quadratic 
trajectory will present the following associations: 
H1:  Low initial symptomatology (intercept) will be associated with successful 
outcomes (the lower the initial level of symptoms, the better outcome) 
H2:  Steep slope (fast change) will predict successful outcome (the steeper the 
slope, the better outcome) 
H3:  High curvature will be associated with successful outcomes (the less 
steady the rate of change, the better outcome) 
Hii:  There will be a pattern of successful outcome in terms of reliable improvement. 
The descending partial “U”-shaped quadratic trajectory will present the following 
associations: 
H4: Low initial symptomatology (intercept) will be associated with reliable 
improvement (the lower the initial level of symptoms, the more reliable 
the improvement) 
H5: Steep slope (fast change) will predict reliable improvement (the steeper 
the slope, the more reliable the improvement) 
H6: High curvature will be associated with reliable improvement (the less 
steady the rate of change, the more reliable the improvement). 
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CHAPTER III 
Method 
Participants 
The sample (N = 492) consisted of community counseling clients who underwent 
weekly psychotherapy sessions at a university counseling training center in the 
Southwest. Therapists were 204 graduate level students (83% were master’s level and 
17% were doctoral level). On average, each clinician provided psychotherapy to 
approximately 2.4 clients (M = 2.4; SD = 1.51; range = 1 to 14) under the supervision of 
licensed psychologists. The majority of the therapists (72%) had 2 or more clients. About 
9% of these therapists had at least one semester of previous practicum experience, and 
5% had prior experience in other work settings. These therapists were 78% female and 
22% male, and the mean age was 28.09 (SD = 5.58; range = 22 to 41).   
Clients provided weekly information on psychological distress, which was 
measured by the Shorter Psychotherapy and Counseling Evaluation (sPaCE; Halstead, 
Leach, & Rust, 2007), as well pre- and post-treatment information of general distress as 
measured by the Outcome Questionnaire-45.2 (OQ-45.2; Lambert, et al., 1996). The 
presenting problems included anxiety, depression, interpersonal problems, anger 
management, family issues, substance abuse, grief, and vocational concerns. The mean 
score of the sPaCE at session 1 was 22.64 (SD = 13.94; range = 5 to 65; 0 = low, 76 = 
high). Norms for the sPaCE show that the initial scores of this sample are close to 
‘general practice’ population norms (lower than psychiatric populations). Mean scores of 
the OQ-45 at session 1 was 73.52 (SD = 23.58; range = 19 to 143; 0 = low, 180= high), 
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which was within the range of OQ-45 norms for this type of population (Lambert et al., 
1996).  
This sample was restricted to only individual psychotherapy clients aged at least 
18 years of age (M = 31; SD = 12.30; range = 18 to 70). Clients attended weekly 
counseling sessions (up to 14). The duration of each session was approximately 50 
minutes.  The inclusion criterion for this study was attending at least 3 sessions in order 
to model change. Approximately 13% attended 3 sessions, 11% attended 4 sessions,  12% 
attended 5 sessions, 11% attended 6 sessions, 10% attended 7 sessions, 11% attended 8 
sessions, 11% attended 9 sessions, 12% attended 10 sessions, 6% attended 11 sessions, 
1% attended 12 sessions, 1% attended 13 sessions, and less than 1% attended 14 sessions.  
The distribution of participants based on different characteristics was as follows. 
Considering gender, 43% were males, 50% were females, 1% were transgender, and 6% 
did not provide gender information. Based on age, 36% were from 18 to 25, 33% were 
from 26 to 35, 19% were from 36 to 49, 8% were over 50, and 4% did not report age. 
Considering ethnicity, 67% were White, 13% were Hispanic, 5% were Asian, 3% were 
African American, 2% were Native American, 1% were mixed race, and 9% did not 
provide information about ethnicity.  
Measures 
OQ-45.2 (Lambert, Hansen, Umpress, Lunen, Okiishi, 1996). The OQ-45.2 is 
a 45-item Likert scale based on five points (0 = Never, 4= Almost always). This 
instrument is typically administered to assess general psychological distress and 
frequently used in process and outcome research. There is a total score and three subscale 
scores. The total score indicates the level of general symptomatology (psychological 
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distress). The subscales indicate specific types of distress such as symptom distress, 
interpersonal relations, and social roles. Past analyses (Wells, Burlingame, Lambert, 
Hoag, & Hope, 1996) indicate that the OQ-45 has good psychometric properties such as 
internal consistency (Cronbach’s α = 0.93) and three-week test-retest reliability (r = 
0.84). Concurrent validity with instruments, such as the Symptom Checklist 90, Beck 
Depression Inventory and Inventory of Interpersonal Problems among others, show 
values ranging from .55 to .88 (Lambert & Vermeersch, 2008). Various studies showed 
additional properties such as sensitivity to change (Vermeersch, Lambert, & Burlingame, 
2000), concurrent validity (Umphress, Lambert, Smart, Barlow, Clouse, & Hensen, 
1997), and construct validity (Bludworth, Tracey, & Glidden-Tracey, 2010; Mueller, 
Lambert, & Burlingame, 1998). The total score was used at intake and termination to 
obtain a measure of final outcome. 
sPaCE (Halstead, Leach, & Rust, 2007). The sPaCE is a 19-item Likert scale 
based on five points (0 = Not at all, 4 = Extremely) and is used as a measure of client 
depression and anxiety symptomology over time. The sPaCE has shown good internal 
consistency (Cronbach’s α = .93 for the total scale and Cronbach’s α = .79 to .88 for 
subscales), two-week test-retest reliability (r = .96), convergent validity with the BDI (r = 
.76), and sensitivity to change (t = 7.40, p < .0005) (Halstead et al., 2007). Convergent 
validity of the Spanish version of the sPaCE with the OQ-45 showed good results (Leiva 
et al., 2010). In addition, the predictive validity was recently examined and findings 
showed that the sPaCE has incremental predictive power regarding final outcome 
(symptomatology as measured by the OQ-45and interpersonal problems as measured by 
the IIP-32) over and above other comparable brief measures such as the OQ-10.2 
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(Jimenez-Arista et al., in press). The sPaCE total score was used on each of the 14 
weekly longitudinal observations to track symptom change over time. 
Procedure 
IRB approval for the study was obtained prior to any data collection. Average rate 
of participation was approximately 58% (58% of clients attending therapy consented to 
participate in the research). Prior to the first session, clients received an information 
packet including purpose and description of the study, participant’s rights concerning 
confidentiality and withdrawing from the study, and a consent form. As part of this 
packet, clients were administered the OQ-45 in order to assess initial levels of distress. 
For all subsequent weeks, they completed the sPaCE questionnaire every time they 
attended a counseling session at the beginning of the visit. Finally, they completed the 
OQ-45 again at the end of the treatment in order to obtain a final measure of distress 
post-treatment. This was a naturalistic study and no experimental interventions were 
done. The initial data collected consisted of 699 subjects. However, 207 subjects did not 
meet the criteria (having attended at least 3 session) and thus, were removed from the 
final sample (N = 492). 
Analysis 
Multilevel LCM in SEM. The model design encompassed three main 
components: (1) a curvilinear trajectory, (2) a multilevel structure to account for therapist 
effects, and (3) a prediction component. First, a quadratic latent curve model (LCM; see 
e.g., Bollen & Curran, 2006) in Structural Equation Modeling (SEM) was used to model 
the non-linear trajectory of the observations over time. This approach allowed for testing 
the first hypothesis (trajectory following a curvilinear pattern of change). LCM is based 
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on a standard linear regression model and includes an additional powered term (i.e., “time 
squared” or “quadratic term”—Q) to model a curvilinear pattern over time (Cohen, 
1978). Time (1 to 14 weeks) was coded subtracting one to the week (week number – 1). 
A quadratic curve is thus represented by latent (non-observed) growth variables: intercept 
(I) or level of symptomatology at time 1, linear term (S) or slope of curve at time 1, and 
quadratic term (Q) or curvature of the trajectory. Loadings between latent growth 
parameters and observations are a function of time: intercept loadings as t
0
 (1), slope 
loadings as t (0 to 13), and quadratic loadings as t
2
 (0, 1, 4, 9, 16..., 169). For cubic 
trajectories, loadings would be represented as t
3
 (0, 1, 8, 27…, 2197). 
Second, the multilevel component was included in order to account for the third 
level in the hierarchical data structure (therapist) and to examine inter-individual 
differences (differences between therapists). Controlling for therapist effects is relevant, 
as omitting this information can lead to biased or inaccurate results (Falkenström et al., 
2013; Owen, Drinane, Idigo, & Valentine, 2015; Tasca, Illing, Joyce, & Ogrodniczuk, 
2009). A multilevel SEM approach proposed by Muthén (1989, 1994) was used in this 
design in order to incorporate the information about therapists. This multilevel approach 
decomposes data in two orthogonal parts (Hox & Maas, 2004): an intra- individual part—
“within” — and a group part — “between” — (within-therapists and between therapists 
in this design). 
Third, a predictive component was added to test the second hypothesis 
(curvilinear trajectory predicting final outcome). The predictors were the latent 
parameters of the best fitting model. The criterion was final outcome. Final outcome was 
measured by taking into account both the pre- and post-treatment scores of OQ-45, given 
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that different clients started with different levels of distress. Experts have examined 
various approaches to assess final outcome in longitudinal research, such as difference-
scores and residual change scores (see e.g., Allison, 1990; Cronbach & Furby, 1970; 
Willet, 1988; Willet, 1997). Difference scores are obtained by subtracting post- from pre-
test scores. Residuals scores can be computed by regressing post-test scores on pre-test 
scores, or by subtracting pre- times the correlation between pre- and post-  from  post-test 
Z scores  using the following formula: RG = Z2 – Z2* r12 (see e.g., Steketee& Chambless, 
1992). 
For this study, residual change scores were used as a measure to represent final 
outcome (OQres) for several reasons. First, residual scores were developed to obtain a 
“measure of individual change that is uncorrelated with initial status” (Willet, 1996, p. 
380).  And second, residual scores not only account for initial differences across 
individuals but also for measurement error (Beutler & Hamblin, 1986; Mintz et al., 1979; 
Steketee & Chambless, 1992). Steketee and Chambless (1992) explain that calculating 
residual scores involves a procuress of re-scaling “an individual’s score relative to typical 
gains made by others at the same initial level” (p. 394). They argue that residual scores 
represent an appropriate measure of change, but given that the interpretation of residual 
change is less intuitive than those of change scores or percent-change scores, the use of 
residuals scores in research has been limited. In general, lower residuals represent more 
change and were an indicator of successful outcome in this study (lower levels of final 
symptomatology after accounting for initial symptomatology). Conversely, higher 
residuals indicate poor outcome (higher levels of final symptomatology after accounting 
for initial symptomatology). 
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To further evaluate the predictive power of the latent growth parameters, 
“reliable improvement” was also used a criterion variable. The Reliable Change Index 
(RCI; Jacobson & Truax, 1991) determines if individual change is statistically reliable. 
Using the RCI is a recommended way to measure change (see e.g., Speer, 1992; Wise, 
2004). The RCI for the OQ-45 is 14 points (Lambert et al., 1996), a cut-off that helps 
identify clients who improve. Therefore, I identified subjects who experienced a decrease 
of 14 points in symptoms, and considered their improvement as reliable change.  A 
binary variable (1, 0) was created to indicate if clients reliably changed from intake to 
termination (1) or not (0), and this variable (reliable improvement) was used as the 
criterion variable in the predictive component along with residuals. See Figure 1 for final 
LCM of the hypothesized quadratic trajectory. 
The three design components described above (curvilinear, multilevel, and 
predictive) were included in the design, and the model building process started with 
simple models. Progressively, more components were added to build more complex 
models (Rodgers, 2010). This approach is recommended, as issues with convergence are 
difficult to manage in more elaborate models. First, a linear model, containing only the 
intercept (I) and the slope (S) parameters, was developed. Next, the multilevel component 
(“within” and “between”) was added to account for therapist effects. Subsequently, a 
quadratic term (Q) was added to create an LCM depicting curvilinear change. Finally, the 
distal outcome (Y) was added to the model by regressing final outcome (residual scores) 
from the latent parameters (e.g., I, S, Q) at both within and between levels. 
  37 
 
Fig. 1. Multilevel Latent Curve Model (multilevel LCM) of 14 longitudinal 
observations (Xi) over time depicting quadratic latent parameters (I = intercept, S = slope, 
Q = quadratic) predicting final outcome (Y) as conceptualized by symptom change 
(residuals) or reliable change at both within- and between-therapist levels. 
 
Model fit was examined at overall model level (Chi-Square Test of Model Fit), as 
well as with multiple fit indices (see e.g., Hu & Bentler, 2000; Kline, 2005). Fit indices 
included, the chi-square test of exact fit, the root mean square error of approximation 
(RMSEA < .08), the standardized root mean square residual (SRMR < .08), the 
comparative fit index (CFI > .90), and the Tucker-Lewis index (TLI > .90). According to 
recommendations, CFI and TLI have to be corrected in order to obtain informative 
indices when RMSEA values are particularly small (Kenny, 2015; Kenny, Kaniskan, & 
McCoach, 2015). Prediction of final outcome was subsequently assessed by examining 
the effect size and significance of the R
2
 values and regression coefficients. 
  38 
Data characteristics. Patterns of missing data were examined prior to the 
analyses. The proportion of missing data was approximately 47% over 14 longitudinal 
observations, with higher proportions of missingness occurring in the last 5 points in 
time. The average number of longitudinal measures collected for each client was 7 (M = 
6.8; SD = 2.63; range = 3 to 14). A Little’s MCAR test was carried out (Little, 1988), and 
results showed that data were not missing completely at random, χ2 (108) = 226,029,725. 
27, p < .001. This makes sense considering that the proportion of missing data was 
particularly high for late observations of sPaCE (t = 10 to t = 14). It is important to note 
that other mechanisms of missing data could have been present (e.g., missing at 
random—MAR or not missing at random—NMAR) but they were not examined. 
Nevertheless, experts contend that using full information maximum likelihood (FIML) 
estimation is appropriate to address missing data under “ignorable data conditions” like 
MCAR or MAR (Enders & Bandalos, 2001; p. 430), so FIML was used in this study. 
FIML allows for the examination of all data in longitudinal studies (as if all subjects were 
measured at each point in time) while dealing with selection bias during the sampling 
process (MacArdle & Grimm, 2014).  
Normality of the data was examined with the Shapiro-Wilk test (Shapiro & Wilk, 
1965). The univariate examinations of each variable showed that the data did not 
approximate a normal distribution (except for sPaCE scores at t = 12, 13, and 14 which 
had high levels of missing data). We therefore used robust maximum likelihood as the 
estimation method. All analyses were conducted in the statistical software Mplus v.7.2 
(Muthén & Muthén, 2014). 
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CHAPTER IV 
Results 
Descriptive Statistics and Initial Data Screening 
Descriptive statistics including means, standard deviations, and correlations 
among longitudinal scores of sPaCE, and pre- and post-OQ45 are included in Table 1. 
Given that data are not independent (clients are nested within therapists), these figures 
should be examined with caution. Measures of sPaCE were strongly correlated with other 
sPaCE observations at different times as expected (.70 < r < .97). They also showed 
moderate to high correlations with scores of OQ-45 at intake (.40 < r < .82) and 
termination (.59 < r < .86). Comparing pre- OQ-45 scores (M = 73.52; SD =23.58) with 
post-OQ-45 scores (M = 63.79; SD = 26.53), there was a decrease in symptomatology at 
the end of the treatment. Similarly, initial sPaCE scores (session = 1; M = 22.64; SD = 
13.94) compared to later scores (session = 10; M = 19.01; SD = 14.48) showed 
symptomatology decrease. 
As clients were nested within therapists, the variability of the data within and 
between groups of therapists was examined. The longitudinal data, as measured by 
sPaCE, was part of a three-level structure: level 1 (longitudinal observations), level 2 
(client), and level 3 (therapist). Final outcome as measured by OQ-45 was part of a two-
level structure (clients and therapists). The intraclass correlation (ICC), which describes 
the distribution of variance across levels, was calculated to examine the nested structure. 
The ICC of the longitudinal data as measured by sPaCE was approximately 13% (ICC = 
.134), meaning that 13% of the variability in the longitudinal data was explained by 
differences between therapists. The ICC of the final outcome variable as measured by 
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OQ-45 (residuals) was less than 1% (.003). In sum, the substantial ICC of the 
longitudinal data supports the model design representing a three- level structure: level 1-
observations over time, level 2- clients, and level 3- therapists.  
Given the high proportion of missing data at the end to the treatment, models at 
time 11 to 14 presented identification issues and did not converge (probably due to low 
variance). The following analyses were carried out using 10 longitudinal observations, 
which represent over 70% of the treatment duration. 
 
Multilevel Latent Curve Modeling (Multilevel LCM) 
A linear model was developed first as a baseline. This model included two latent 
growth parameters (intercept—I and slope—S). Between- and within- therapist 
components were included in order to account for the multilevel structure. Model fit of 
the multilevel linear model was examined through the Chi-Square Test of Model fit and 
individual fit indices, which showed a moderate fit (χ2 (92) = 176.619, p < .001; RMSEA 
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= .043; SRMRwithin = .024; SRMRbetween = .006; CFI = .711; TLI = .695). See model fit 
statistics in Table 2. 
 
 
Next, a quadratic term (Q) was added to the baseline (multilevel linear) model in 
order to build a curvilinear quadratic trajectory of change. This included the three latent 
growth parameters (intercept—I, slope—S, and quadratic term—Q) at within and 
between levels. The overall model fit and fit indices showed that the quadratic model fit 
the data well (χ2 (85) = 134.989, p < .001; RMSEA = .035; SRMRwithin = .02; SRMRbetween 
= .038; CFI = .829; TLI = .805).  
Given that some studies identified cubic patterns (e.g., Vermote et al., 2009), a 
cubic model was tested. Mean scores of this sample showed a drop in symptoms by 
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session six (M = 19.02), followed by an increase in symptoms in session seven (M = 
19.93), potentially suggesting a cubic trend. A cubic model was thus estimated by adding 
a cubic term (C) to the quadratic model. Even though individual fit indices for the cubic 
model showed acceptable values in terms of cut off criteria, both the cubic term and the 
test of model fit were not significant (χ2 (76) = 69.357, p = .69; RMSEA = .000; 
SRMRwithin = .016; SRMRbetween = .033; CFI = 1.000; TLI = 1.000). 
Given that the cubic model was not significant, the linear and the quadratic 
models were compared.  The Chi-Square values of the linear model (χ2 (92) = 176.619, p 
< .001) and the quadratic model (χ2 (85) = 134.989, p < .001) were examined. Results of 
the Likelihood Ratio Chi-Squared difference test showed that the quadratic growth curve 
was significantly better than the linear curve (χ2 (7) = 41.63, p < .001). Also, lower values 
of RMSEA and SRMR and higher values of CFI and TLI supported the superiority of the 
quadratic model. Moreover, the coefficient of the quadratic term was significant (t = 
2.270, p = .023), justifying the quadratic term in order to represent the growth curve (see 
Fig. 2 for estimated mean quadratic trajectory of data).  
A visual inspection of the average quadratic trajectory showed additional 
characteristics. The trajectory showed steeper slopes in the first 4 to 5 sessions and then, 
symptoms leveled off. This was confirmed by obtaining tangents (values of the slopes at 
individual points in time such as t = 1, 2, 3, etc.), calculated with the derivative of the 
quadratic equation. Values of theses slopes showed less steep tangents starting around 
time 5.  
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Fig. 2. Estimated mean symptomatology change trajectory as measured by sPaCE 
To further identity differences in individual sPaCE quadratic trajectories within 
clusters of clients of a given therapist and across therapists, the means, variances, and 
correlations of the latent parameters (IW, SW, QW, IB, SB, and QB) were examined (see 
Table 2 and Table 3). The overall mean intercept (M = 22.690; SD = 13.94; p < .001; 
range = 5 to 65; 0 = low; 76 = high) indicated that on average, clients started with a 
moderate level of distress of 22.690 at session one (intake). The negative mean slope at 
session one (M = -0.872, p < .001) indicates a decreasing rate of change (decreasing 
symptomatology). The mean quadratic term describes a small level of curvature (M = 
0.046, p = 0.023). The tree growth parameters depict a descending quadratic curve 
(partial “U”-shaped) with small curvature. The time-1 variance of the intercepts and 
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slopes at both within-therapist (IW, SW) and between-therapists level (IB, SB) were 
significant. This indicates that individual initial symptomatology differ from the mean 
initial symptomatology. This variance was particularly high at within-therapist level (var 
= 140.339, p < .001) suggesting that clients of the same therapist widely vary in terms of 
initial symptomatology.  Correlation values indicate that there were associations among 
latent growth parameters. Some correlations were particularly high, such as between SW 
and QW, and SB and QB. 
Table 3. Correlations among quadratic latent growth parameters at both within- and between therapist 
levels 
   Parameter 1 2 3 4 5 6 
 1. Intercept within -IW 1.00 
      2. Slope within -SW 0.34 1.00 
     3. Quadratic within- QW -0.69 -0.92 1.00 
    4. Intercept between- IB 0.48 0.10 -0.29 1.00 
   5. Slope between- SB -0.03 0.20 -0.12 -0.46 1.00 
  6. Quadratic between- QB -0.02 -0.21 0.15 0.37 -0.99 1.00 
  
In sum, results showed support for a quadratic trajectory. The three pieces of 
information (the model fit indices, the Likelihood Ratio Chi-Squared difference test, and 
the significance of the quadratic term) supported a downward quadratic growth curve 
model with clients nested within therapists. This provided the foundation to test the 
hypotheses. 
Next, the predictive component was added to the quadratic model. Predictors 
were the latent growth parameters (intercept—I, slope—S, and quadratic—Q), and they 
were added at both within- (IW, SW, QW) and between-therapist (IB, SB, QB) levels. 
Criterion variables were the residuals of post-OQ45 regressed on pre-OQ45 (OQRes) as 
well as the RCI. Prediction was tested at both within- and between-therapist levels.  
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A correlation assessment of the predictors showed moderate to high 
multicollinearity among the latent growth parameters at both within-therapist level (IW, 
SW, QW; .34 < | r | < .92) and between-therapist level (IB, SB, QB; .12 < | r | < .99). 
Multicollinearity between SW and QW (r = -.92) and QB and SB (r = -.99) were 
particularly high. Also, the high variance inflation factor (VIF) scores for these latent 
growth variables supported the presence of high multicollinearity. High predictor 
collinearity makes the interpretation regression coefficients challenging and may lead to 
imprecise estimations (see e.g., Hutcheson & Sofroniou, 1999).  
The quadratic model with all predictors at within- (IW, SW, QW) and between-
therapist (IB, SB, QB) did not converge even after predictors were centered, most 
probably due to the high multicollinearity among predictors. To solve this issue, 
predictors (latent growth parameters) were included individually and multiple models 
were estimated (see Table 4 for regression results).   
I estimated models 1 to 3 to test hypotheses with residuals (change in symptoms) 
as the criterion variable (lower residuals indicate successful outcome and higher residuals 
indicate poor outcome). Models marked as “a” examined within-therapist effects and 
models marked as “b” examined between-therapist effects. Models 1a and 1b tested 
hypothesis 1 (high initial symptomatology will be associated with poor outcomes). 
Models 2a and 2b tested hypothesis 2 (steeper slopes will predict good outcomes). Model 
3a and 3b tested hypothesis 3 (high curvature will be associated with good outcomes).  
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Table 4. Regression Results. Predicting Final Outcome by Sets of Predictors (N = 492) 
     
Model parameters by criterion variable R
2
within R
2
between B (SEB) β 
Residual Models         
       1a. Quadratic residuals -IW .16** 
   
           IW 
  
0.016 
(0.003)** 0.404** 
       1b. Quadratic residuals -IB 
 
.96** 
             IB 
  
0.028 (.008)** 0.981** 
       2a. Quadratic residuals -SW  .38** 
              SW 
  
 0.194 (0.36)** 0.615** 
       2b. Quadratic residuals -SB 
 
† 
             SB 
  
0.864 (.027)** 1.080** 
       3a. Quadratic residuals- QW .28* 
              QW 
  
-2.732 (.612)** -0.529** 
       3b. Quadratic residuals- QB 
 
† 
             QB 
  
-5.967 (.111)** -1.04** 
RCI models 
           4a. Quadratic RCI -IW .01 
              IW 
  
-0.004 (.003) -0.098 
       4b. Quadratic RCI -IB 
 
.83 
             IB 
  
-.021 (.011)* -0.91 
       5a. Quadratic RCI- SW .12* 
   
           SW 
  
-0.112 
(0.023)** -0.35** 
       5b. Quadratic RCI- SB 
 
.01 
             SB 
  
.006 (.197) 0.091 
       6a. Quadratic RCI- QW .06 
              QW 
  
1.729 (0.481)** 0.24 
       6b. Quadratic RCI- QB 
 
.04 
             QB     .120 (3.172) 0.208 
Note:     IW = intercept within; SW= slope within; QW= quadratic within;  
              IB = intercept between; SB= slope between; QB= quadratic between;                
              RCI= Reliable Change Index;  *p < .05, **p < .01,   † = undefined 
 
For the hypotheses with reliable improvement as criterion, I estimated models 4 to 
6. Models marked as “a” examined within-therapist effects and models marked as “b” 
examined between-therapist effects. Model 4a and 4b tested hypothesis 4 (low initial 
symptomatology will be associated with reliable improvement from intake to 
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termination). Models 5a and 5b tested hypothesis 5 (steeper slopes will predict reliable 
improvement from intake to termination). Models 6a and 6b tested hypothesis 6 (high 
curvature will be associated with reliable improvement from intake to termination). 
Results using individual predictors at within-therapist level showed significant R
2
 
values and coefficients. Results using individual predictors at between-therapist level 
showed high or undefined R
2
 values. However, coefficients were significant. The high R
2
 
values are potentially due to the low intraclass correlation of level-2 variables, such as 
OQ-45 residuals (ICCresiduals = .003). This ICC for residuals suggests that level-2 
variables within therapists appear to be no more similar than the values from different 
therapists. However, experts warn that low ICC values do not always justify not using 
multilevel designs (Nezlek, 2008). Little between-group variability within a measure does 
not mean the relation between this measure (e.g., residuals) and other measures (e.g., 
latent growth parameters) is the same across clusters (Nezlek, 2008). Moreover, the ICC 
of the level-1longitudinal observations (sPaCE) was substantial (ICCsPaCE = .134), and 
thus the multilevel approach was justified. Furthermore, Muthén (2014) argues that when 
the sampling distribution or R
2
 is not close to a normal distribution, it might affect R
2
 
values, and focusing on the coefficients is advised. Considering all these factors, the 
analysis of the results will focus on coefficients (see Table 4 for regression results). 
The results showed confirming results for the hypotheses. Findings using 
residuals as criterion are as follows. Models 1a and 1b, which contained the intercept 
(initial symptomatology) as predictor, showed that higher initial symptomatology was 
associated with poor outcomes at within- and between-therapist levels, supporting 
hypothesis 1. Models 2a and 2b tested the initial slope as predictor. Results showed that 
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more positive (upward) slopes are associated with poor outcome and more negative 
(downward) slopes are associated with good outcome at within- and between-therapist 
levels. This finding supported hypothesis 2. Models 3a and 3b tested the level of 
curvature as a predictor of final outcome. Results showed that higher curvature was 
associated with better outcomes at within- and between-therapist levels. This finding 
supported hypothesis 3. In sum, models 1 to 3 suggested that the growth parameters 
accounted for up to 38% of the variance in final outcome (symptom change in general 
distress) as assessed by the OQ-45.2. They showed that low initial symptomatology, steep 
downward slopes, and high curvature were associated with better outcomes. In contrast, 
high initial symptomatology, flatter or upward slopes and low curvature were associated 
with poor outcomes. 
Results using reliable improvement as criterion are as follows. Models 4a and 4b 
tested hypothesis 4 (high initial symptomatology will be associated with reliable 
improvement). Results showed an inverse association between initial symptomatology 
and reliable improvement at between-therapist level only (the higher the initial 
symptomatology, the lower the reliable improvement). Hypothesis 4 was supported at 
between-therapist level. Models 5a and 5b tested hypothesis 5 and included the initial 
slope as predictor. The negative coefficient showed an inverse association between the 
slope and reliable improvement: more negative (downward) slopes are associated with 
reliable improvement at within-therapist level. These results supported hypothesis 5. 
Models 6a and 6b tested the level of curvature as a predictor of final outcome. Results 
showed that a high curvature was associated with better outcomes at within-therapist 
level. This finding supported hypothesis 6 at within-therapist level. In sum, results of 
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models 4 to 6 suggested that the growth parameters accounted for up to 12% of the 
variance in reliable improvement from intake to termination. For reliable improvement at 
within-therapist level, successful outcomes followed a pattern of high initial rate of 
change (slope) and high curvature.  For reliable improvement at between-therapist level, 
successful outcomes were associated with a pattern of low initial levels of depression and 
anxiety.  
There are four main conclusions based on the results. First, a descending 
quadratic curve (partial “U”-shaped) best described symptomatology change in 
depression and anxiety.  Second, there are multilevel patterns of change associating 
characteristics of the curve and outcome. Third, the pattern for successful outcome in 
terms of symptom change (lower levels of symptomatology) at both within- and between-
therapist levels is: low initial symptomatology, steep downward initial slopes (high initial 
rates of change), and high curvature. Finally, the pattern for reliable improvement had 
differences at within- and between therapist levels. At within-therapist level, the pattern 
was steep downward initial slopes (high initial rates of change) and high curvature. At 
between-therapist level, the pattern was low initial symptomatology. Next, I will discuss 
these findings providing interpretations and highlighting conclusions.  I also present 
implications for practice, limitation of this study, as well as future recommendations. 
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CHAPTER V 
Discussion 
Patterns of change can contribute to the understanding of the mechanisms that 
make psychotherapy work. This can be done by pinpointing key times during the 
treatment when substantial change is occurring or not, and determining if the way 
symptoms evolve (e.g., levels of symptomatology at different times, rate of change) is 
related to final treatment outcome. Past studies primarily focused on patterns by 
subgroups (latent classes) associated to final outcome. Characteristics of the change curve 
(e.g., initial symptomatology, rate of change, variability in the rate of change) and the 
association with outcome have been examined separately rather than as a whole. In 
addition, data dependency and therapist effects due to the multilevel nature of 
psychotherapy data have been disregarded.  
These aspects were addressed in the present study using a multilevel latent change 
curve analysis. The sPaCE (Halstead et al., 2007), a measure that captures two of the 
most common presenting problems in therapy, depression and anxiety, was used to 
measure longitudinal symptomatology. The OQ-45.2 (Lambert, et al., 1996) was used to 
assess final outcome (pre- to post- treatment gain) in general symptomatology.  After 
finding support for a quadratic trajectory of change, major findings of this study are the 
identification of patterns of change associated with good and poor outcomes. The shape 
of the mean trajectory found in this study will be briefly addressed first. Then findings 
related to patterns of change with outcome will be discussed subsequently. 
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Shape of the Average Curve 
First off, a multilevel model approach was followed to address the lack of 
independence in the data (clients nested within therapists). As argued by other 
researchers, controlling for therapist differences and addressing the lack of data 
independence in the design is crucial and recommended regardless of the level of the 
effect (Falkenström et al., 2013). In this study, results showed a substantial proportion of 
variance in the longitudinal data (13%) explained by differences in therapists.  
Three multilevel trajectories were estimated: linear, quadratic, and cubic. The 
results provided support for a quadratic trajectory. Even though there was a drop in 
symptoms by session six (M = 19.02), followed by an increase in symptoms in session 
seven (M = 19.93), this single drop in session six did not support a cubic trajectory. The 
quadratic trajectory was significant and superior compared to the linear and cubic 
trajectories. Accordingly, this mean trajectory of depression and anxiety symptomatology 
depicts a descending quadratic curve (partial “U”-shaped). There is an important decrease 
in symptoms in the first 4 to 5 sessions followed by symptoms that level off and the 
trajectory presents a low curvature over time.  
Mean quadratic trajectories with similar early decrease of symptoms have been 
found in single-level studies in depression and anxiety. For instance, Ilardi and Craighead 
(1994) identified substantial reduction of symptoms by session 4, followed by symptoms 
that leveled off in a sample of clients with depression. Similarly, Kopta et al. (1994) 
found that clients with acute distress symptoms (anxiety, depression, somatization, and 
compulsive behavior) showed significant improvement (50%) by session 5. A similar 
pattern of early improvement (by session 4 or 5) has been identified in the change 
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trajectories of other presenting problems besides depression, such as panic disorder 
(Penava et al., 1998) and bulimia (Grilo et al., 2001).  
In sum, the examination of different trajectories showed that the mean trajectory 
depicts a descending quadratic curve (partial “U”-shaped) with an important decrease in 
symptoms in the first 4 to 5 sessions followed by symptoms that level off, and the 
trajectory shows low overall curvature. It is important to note that this is the shape of the 
average trajectory, encompassing clients with successful and unsuccessful outcomes. 
Factors that predict successful outcomes will be discussed next. 
Predicting Final Outcome 
A multilevel quadratic trajectory of change was modeled and the characteristics of 
the curve (initial symptomatology, rate of change, and curvature) as represented by the 
growth parameters (I, S, Q) were used as predictors at within- and between-therapist 
levels. First, I expected initial symptomatology (initial sPaCE scores) to predict final 
outcome (low initial symptomatology to be associated with higher change in symptoms) 
and this argument was supported. Clients with higher initial depression and anxiety 
distress as measured by the sPaCE had less successful outcomes in terms of general 
symptomatology at termination as measured by the OQ-45.2. This finding is consistent 
with the literature. Past research has shown that low initial depression symptomatology is 
associated with positive outcomes (Allart-van Dam, Hosman, Hoogduin & Schaap, 
2007). Conversely, clients with high symptom severity are frequently non-responders 
(see e.g., Taylor & McLean, 1993; Thibodeau et al,, 2014) or have poor outcomes 
(Herzog, Hartman, Sandholz, & Stammer, 1991), and only a portion of them recover with 
follow-up or post-treatment (Durham, Higgins, Chambers, Swan, & Dow, 2012). I also 
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expected the same effect with reliable improvement as criterion, hypothesizing that high 
depression and anxiety symptomatology as measured by the sPaCE would be associated 
with higher reliable improvement in general symptomatology. For reliable improvement, 
this was supported at between-therapist level. In sum, low initial symptomatology is 
related to change in symptoms at both within- and between therapist levels, and to 
reliable improvement at between-therapist level. 
Second, fast initial change (steep downward initial slopes) predicted successful 
outcome. Fast change at session 1 in depression and anxiety was associated with higher 
reduction of general symptoms at termination. Fast initial change also predicted reliable 
improvement at between-therapist level. This is consistent with past studies that found 
associations between early decrease of symptoms and final symptom change or reliable 
improvement at termination (e.g., Haas et al., 2002; Lutz et al., 2009, 2014; Renaud et al., 
1998; Stulz et al., 2007).  
Fast early change may be related to several factors. For instance, Wright and 
colleagues (2014) argue that clients may seek services when distress is very high, 
responding fast to either specific interventions or common factors. The power of common 
factors early in the treatment might exert an important influence in early change, as 
researches have tested how early change can occur before introducing specific techniques 
(Ilardi & Craighead, 1994). Boswell and colleagues (2012) explain rapid improvement as 
an effect of readiness to change, which moderates initial levels of symptomatology and 
change. In addition, the “flight into health” or important realizations occurring at the 
beginning of the treatment of phenomenon might be related as well (Lambert, 2007; 
2015). Further, a placebo effect experienced early in therapy might be related as well (see 
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e.g., Hubble, Duncan, Miller & Wampold, 2010). Experts have studied the power of 
placebos in psychotherapy (expectations, hope, remoralization, or the therapeutic 
relationship), and they have found that psychological placebos can be as effective as 
treatment (Wampold et al., 2015). Nevertheless, experts ultimately contend that the active 
factors linking early response to outcome are still unknown (Lambert, 2015). It is also 
important to highlight that distinguishing realistic from unrealistic or ‘feigned’ fast 
improvement is a relevant topic, especially in some problems such as suicidality, as 
clients may deny symptoms to avoid treatment or to leave treatment prematurely 
(Sholevar, 2008; Simon & Gutheil, 2009). In sum, results concerning initial rate of 
change (slope) indicated that change that is fast in the beginning (steep downward initial 
slopes) favors symptom change at both within- and between-therapist levels. Also, 
change that is fast in the beginning favors reliable improvement at within-therapist level 
only.  
Third, high levels of curvature predicted successful outcomes: the more curvature 
(less linearity), the higher change clients showed at termination. Similarly, the less 
curvature, the less change in symptoms was present (this association applies only at 
within-therapist level when predicting reliable improvement). Results confirmed that 
curvature is more conducive to good outcome and it can be explained as follows. 
Multiple findings have consistently suggested that change is not linear (see e.g., Hayes et 
al., 2007). Lutz and colleagues (2009), for instance, found a specific pattern in a 
subgroup (an ‘early improvement’ latent class) with higher curvature compared to others 
subgroups with less curvature (more linear). This subgroup was associated with better 
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outcomes, as these clients showed the highest reliable improvement. The other patterns 
showed more linear trajectories and attained less reliable improvement.  
In addition, high curvature might be associated with more major or “sudden” 
between-session improvement shifts and with a lack of worsening shifts at individual 
level (details that cannot be seen in the mean trajectory). For instance, successful 
subgroups presented high frequency of major improvement shifts (Lutz et al., 2009). 
Levels of “non-linearity” and “discontinuity” had been associated with recovery in other 
studies. Thompson and colleagues (1995) found a positive correlation between overall 
levels of non-linearity and recovery rate. They explained that clients with the greatest 
improvement had “unsteady rates of depression reduction” (p. 334). Furthermore, a level 
of homeostasis occurring later in the treatment and showing symptoms that level off 
might also be creating a curvature. This may also be related to the dose-effect relation, 
which indicates that the effect of therapy increases more slowly as therapy progresses 
(see e.g., Barkham et al., 2006; Dekker et al., 2005; Kadera, Lambert, & Andrews 1996; 
Kopta, 2003; Lutz, Lowry, Kopta, Einstein, & Howard, 2001). Finally, patterns found in 
previous studies about depression depict curvilinear quadratic change (“change in the rate 
of change”) with  early rapid response and symptoms that level off, and these patterns 
were associated with improvement (e.g., Grilo et al., 2006; Penava et al., 1998). The 
early response rate and substantial decrease in symptoms implies higher curvature. All 
in all, these studies suggest that high curvature is related to successful outcomes and give 
support to the results obtained in the present study. 
For reliable improvement, findings did not apply at both levels (within- and 
between-therapist). Nevertheless, the direction of the association (direct/inverse) was 
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consistent with that of the residuals. At within-therapist level, steeper slope and high 
curvature were significant predictors. This means that for a given therapist, clients that 
change rapidly in the beginning will have better results than clients of the same therapist 
that change slowly in the beginning. Similarly, for a given therapist, clients with a higher 
curvature will have better results than clients of the same therapist with less curvature. At 
between-therapist level, only low initial symptomatology was a significant predictor. 
Thus, a therapist that on average his or her clients started with less severe initial 
symptoms,  will have better results than other therapists with more severe symptoms on 
average. Reliable improvement was a dichotomous variable (yes/no) and a more ‘strict’ 
criterion compared to “change in symptoms” (residuals). Nevertheless, findings obtained 
for residuals (change in symptoms) in this study still have utility, as the idea of 
significant (reliable) change may be a subjective concept, and minor change might be 
meaningful depending on the individual or situation. 
As an additional finding, these results also support the power of the sPaCE (as a 
measure that captures depression and anxiety) to predict change in general 
symptomatology. It is known that depression correlates with other psychopathologies, 
including substance use, non-affective disorders, disruptive behavior disorders, bipolar 
disorder, eating disorders, or general distress (see e.g., Gotlib, 1984; Gotlib, Lewinsohn, 
& Seeley, 1995; Kaufman & Charney, 2000; Rohde, Lewinsohn, & Seeley, 1991). In this 
study, the sPaCE showed the ability to predict change in general symptom distress as 
measured by the OQ-45.2. This supports previous studies about the predictive power of 
the sPaCE. For instance, the incremental validity of the sPaCE in terms of explanatory 
power compared to other measures was supported in a multilevel (bilevel) design 
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(Jimenez-Arista et al., in press). The sPaCE explained up to 12% of the variance in 
outcome measures of general symptomatology (OQ-45.2; Lambert et al., 1996) and up to 
7% of the variance in interpersonal distress (IIP-32; Horowitz, Alden, Wiggins, & Pincus, 
2000).  
In sum, work done in the past examined some of the characteristics of the curve 
(initial level of symptoms, rate of change, curvature) separately and mainly by subgroups 
(latent classes). Multilevel approaches had not been followed. In this multilevel study, all 
of the three aspects were included to find patterns of change for successful and 
unsuccessful outcomes. First, I obtained a mean change curve: a descending quadratic, 
“U”-shaped trajectory with early improvement (first 4 to 5 session). In contrast to other 
studies based on subgroups, I used the aggregated information of the entire sample (rather 
than subgroups) to predict outcome and found patterns for successful and successful 
treatment. The quadratic growth curve of depression and anxiety had predictive power for 
both final outcome and reliable improvement in general symptomatology. Patterns for 
successful outcomes included low initial levels of depression and anxiety, steep 
downward slopes at session one, and high curvature. Finally, patterns for poor outcomes 
included high initial levels of depression and anxiety, flat or steep upward slopes at 
session one, and low curvature. 
 Implications for Practice 
           As mentioned, studying the shape of the symptomatology curve is relevant in 
order to understand the rate of change over time, identify when most change takes place, 
determine an optimal number of sessions, and analyze how individual trajectories differ 
from average trajectories. This can ultimately help us have better outcomes with clients. 
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The findings from this study shed light on various practical aspects. First, 
clinicians can expect that progress for the average client is not steady. This is consistent 
with past findings (see e.g., Cannon et al., 2010; Hayes et al., 2007; Rasmus et al., 2007). 
Second, a pattern for successful outcomes was found. Clinicians can expect that clients 
who follow this pattern (low initial levels of depression and anxiety, steep downward 
slopes at session one, and high curvature) can potentially have significant reduction in 
symptoms. Likewise, if clients are deviating from this trajectory, clinicians can suspect 
poor final outcomes. This is an opportunity for clinicians to change their therapeutic 
approach in the middle of the treatment and attempt to obtain better responses. Owen and 
colleagues (2015) advise, “[w]hen clients are not progressing as expected, therapists are 
encouraged to address alliance issues, change their approach to treatment, or address 
other external factors that might be negatively affecting treatment” (p. 817). 
Third, clinicians can be cognizant when, on average, more change occurs. The 
average curve found in this study showed early response and supported past research (see 
e.g., Grilo et al., 2001; Ilardi et al., 1994; Penava et al., 1998) indicating that faster 
change happened in the first 4 to 5 sessions. Clinicians typically expect to have longer 
treatments or less desirable outcomes with late-responders (Roth & Fonagy, 2015), and 
treatment has been adjusted to provide additional support at follow-up for those clients 
(Haan et al., 1997). However, fast change in the first session for high risk client (e.g., 
suicidal behaviors) might not be conducive to good outcomes, as it can represent 
unrealistic change related to phenomena such as “flight into health,” overcompensation, 
psychological placebo, feigning to terminate treatment, or change that lacks sufficient 
preparation.  
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Fourth, it is expected that not all clients will follow the same pattern conducive to 
successful outcomes. Responsiveness from clients varies widely and clients present 
different types of patterns. However, adequate and timely response from therapists is 
needed when clients show poor response trends. Stiles (2013) contends that, 
“appropriately responsive therapists adapt their interventions to these variations” (p. 38). 
Therapist responsiveness, as part of clinical competence, involves using constant 
information of clients’ progress to pursue positive outcomes (Stiles, 2009). The 
importance of progress monitoring comes into play here (see e.g., Boswell et al., 2013; 
Lambert & Vermeersch, 2008). Clinicians can better respond and adjust interventions if 
they have clearer information about outcomes during the course of the treatment. 
Limitations and Future Directions  
The generalizability of these findings depends on several factors, such as the 
amount of data obtained as well as the characteristics of the sample. Concerning the data 
collection, there were considerable missing data similar to most  longitudinal research. 
Data were particularly missing at the end of the treatment, and the average number of 
observations collected for each client was about 5. This number represents the measures 
that were obtained and not necessarily treatment attendance (clients might have attended 
more sessions without completing the questionnaires). Missing data were appropriately 
handled with recommended techniques, but it is possible that analyzing the 14 sessions 
instead of 10 would have yielded different results, as it is known that the frequency of 
measures impacts the ‘precision’ of the analyses (Cook & Ware, 1983; Schaie, 1986; 
Laurenceau et al., 2007; Schmidt & Teti, 2005). In addition, the high multicollinearity 
among predictors led to estimating separate models with single predictors, given that 
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multi-predictor models did not converge. Nevertheless, regression results and coefficients 
using residuals and reliable change as criterion variables were consistent with each other, 
providing reassurance about the results obtained.  
In terms of the sample, no participants were excluded as long as they attended at 
least three sessions. However, clients who were willing to participate might have had 
different characteristics than the ones who decided not to be part of the study. For 
instance, it is unknown if the level of initial symptomatology affected clients’ willingness 
to participate. As this was a naturalistic study, a variety of client presenting problems and 
therapist theoretical orientations were involved. Further, this sample included community 
clients; therefore, features of other populations (e.g., residential programs, psychiatric 
outpatient facilities) might not have been captured. The presenting problems in 
psychiatric populations are typically more severe and might require longer treatments and 
more time to show initial response, affecting the shape of the mean curve and the patterns 
of change for successful and unsuccessful treatment. 
One additional factor to consider is the ethnic mix of this research. Minorities 
were underrepresented in this study, as seen in the differences between the ethnic 
composition and percentages in the general populating (U.S. Census Bureau, 2010) for 
the following groups: Hispanics (13% in this study versus 17% in the general 
population), African Americans (3% versus 12%), Asians (3% versus 6%), and Native 
Americans (1% versus 2%). Nevertheless, ethnic minorities continue to be 
underrepresented in mental health services (Holden et al., 2014; Leong & Zalibatseva, 
2011; Miranda, 1996), so this sample might be similar to community clinical populations. 
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The contribution of this study was the understanding of patterns of change and 
how they predict therapy outcome: low initial symptomatology, fast initial rate of change 
and high curvature favors successful outcomes. To expand this understanding, further 
research might focus on explaining what makes clients present early responses and what 
makes the symptoms level off. Additional studies to examine factors (from the client or 
the therapist side) are still needed. Continuing to take therapists effects into account is 
relevant to avoid overstating precision and potentially biased results, and to obtain more 
comprehensive findings.  
Another area of opportunity in the study of patterns of change is the examination 
of “sudden gains” which have been explored in single level analyses (see e.g., Tag & 
DeRubeis, 1999; Tang et al., 2002). Examining if sudden gains are related to some of the 
findings of this study (high curvature) by using a multilevel model and determining if 
gains are ultimately related to final treatment would be a further step.  
Finally, this study followed a macro-analytic approach, examining session to 
session information. New trends in psychotherapy process include the use of within-
session “microanalytic approaches,” focusing on moment-to-moment behavior and 
examining the interrelation of variables at a given moment (see e.g., Busch et al., 2010; 
Greenberg, 2015). This approach can help researchers and practitioners first, 
understanding specific behavior within the session and context (Greenberg, 2015) and 
second, provide adequate and contingent responses (Kohlenberg & Tsai, 1991). As such, 
patterns of change can be studied from a microanalytic perspective, attempting to 
understand what lead to early change in each one of the first five sessions. The context 
and complexity of human behavior must be taken into account. Psychotherapy is a 
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“reciprocal process” with non-predictable inputs that constantly change during the 
interaction of the participants (Hubble et al., 2010; p. 34). To conclude, there are still 
many process research areas to explore. As psychotherapy research continues to evolve in 
focus and methodologies, the main question, ‘how therapy works,’ continues to offer a 
myriad of possibilities in the attainment of knowledge for the application in practice. 
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     TITLE: Regress Residuals on Intercept-Between 
      DATA: FILE IS MasterSPACE.dat; 
      VARIABLE: NAMES ARE  Client ther_id   SP1 sp2 SP3 SP4
 SP5 SP6 SP7 SP8 SP9 SP10  resids  RC; 
      USEVARIABLES = sp1-sp10 resids; 
      missing = .; 
      CLUSTER = ther_ID; 
 
 
      ANALYSIS: 
      ESTIMATOR = mlr; 
      COVERAGE = 0; 
      H1ITERATIONS = 1000000; 
      TYPE = TWOLEVEL; 
      MITERATIONS = 10000; 
 
      MODEL: 
      %WITHIN% 
 iw sw qw| sp1@0 sp2@1 sp3@2 sp4@3 sp5@4 sp6@5 sp7@6 sp8@7 sp9@8 
sp10@9; 
             iw sw WITH qw; 
 
      %BETWEEN% 
          ib sb qb| sp1@0 sp2@1 sp3@2 sp4@3 sp5@4 sp6@5 sp7@6 sp8@7 sp9@8  
          sp10@9; 
         ib sb WITH qb; 
         resids ON ib; 
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CONSENT FORM for CTC Clients 
Examination of the counseling process 
 
The purposes of this form are to provide you (as a prospective research study participant) 
information that may affect your decision as to whether or not to participate in this 
research and to record the consent of those who agree to be involved in the study. 
Participation is voluntary and will not affect the counseling services you receive as a 
client at the CTC. 
RESEARCHERS 
Professors Cynthia Glidden-Tracey, Terence Tracey, and Lisa Spanierman are a research 
team in the College of Letters and Sciences at Arizona State University and are inviting 
your participation in a research study.  
STUDY PURPOSE 
The purpose of the research is to clarify symptom and counseling process variables that 
will be used to track client progress over the course of counseling. 
DESCRIPTION OF RESEARCH STUDY 
If you decide to participate, then you will join a study in which we examine the changes 
in your concerns over the course of counseling. Your participation will involve filling 
out a symptom checklist like the one you have just completed prior to each of the 
counseling sessions. You will also be asked to complete a short questionnaire about 
your experience in counseling. In order to complete the questionnaires each week, you 
will be asked to arrive 5-10 minutes before each session. In addition, if you agree to 
participate please arrive 15 minutes early before your next session to complete a brief 
packet of 3 questionnaires, which we ask participants to complete at the beginning and 
the end of the semester. If you say YES, then your participation will last until the end of 
your counseling at the Counselor Training Center (CTC). Approximately 50-60 clients 
will be participating in this study this semester at the CTC.  
RISKS 
There are no known risks from taking part in this study, but in any research, there is some 
possibility that you may be subject to risks that have not yet been identified. 
BENEFITS  
Although there may be no direct benefits to you, the possible benefits of your 
participation in the research are that we may learn more about the questionnaires we use 
as well as how they provide information over the course of counseling. 
 
CONFIDENTIALITY 
All information obtained in this study is strictly confidential. The results of this research 
study may be used in reports, presentations, and publications, but the researchers will not 
identify you.  In order to maintain confidentiality of your records, Professor Glidden-
Tracey will ensure that all data will be number coded and that the list associating your 
name with the code number will be locked in a secure cabinet and destroyed at the 
conclusion of the study. Only the research team will have access to those code numbers.  
WITHDRAWAL PRIVILEGE 
  85 
Participation in this study is completely voluntary. It is ok for you to say no. Even if you 
say yes now, you are free to say no later, and withdraw from the study at any time. Your 
decision will not affect your receipt of services from the CTC. Nor will it affect your 
relationship with Arizona State University or otherwise cause a loss of benefits to which 
you might otherwise be entitled. Withdrawal from the study will mean that you will not 
be requested to complete any more forms but that the forms you completed to date can 
still be used in data analysis. If you wish your information previously completed to be 
deleted, please inform the research team. 
COSTS AND PAYMENTS 
There is no payment for your participation in the study. 
VOLUNTARY CONSENT 
Any questions you have concerning the research study or your participation in the study, 
before or after your consent, will be answered by members of the research team 
(Professor Cynthia Glidden-Tracey, 480-965-5067, Professor Terence Tracey, 480-965-
6159, or Professor Lisa Spanierman, 480-727-2605, all at 446 Payne Hall). 
If you have questions about your rights as a subject/participant in this research, or if you 
feel you have been placed at risk; you can contact the Chair of the Human Subjects 
Institutional 
Review Board, through the ASU Research Compliance Office, at 480-965-6788.   
This form explains the nature, demands, benefits and any risk of the project.  By signing 
this form you agree knowingly to assume any risks involved.  Remember, your 
participation is voluntary.  You may choose not to participate or to withdraw your 
consent and discontinue participation at any time without penalty or loss of benefit.  In 
signing this consent form, you are not waiving any legal claims, rights, or remedies.  A 
copy of this consent form will be given upon request.   
Typing your name below indicates that you consent to participate in the above study.   
 
___________________________ _________________________ ____________ 
Subject's Signature   Printed Name    Date 
INVESTIGATOR’S STATEMENT 
"I certify that I have explained to the above individual the nature and purpose, the 
potential 
benefits and possible risks associated with participation in this research study, have 
answered 
any questions that have been raised, and have witnessed the above signature. These 
elements of Informed Consent conform to the Assurance given by Arizona State 
University to the Office for Human Research Protections to protect the rights of human 
subjects. I have provided (offered) the subject/participant a copy of this signed consent 
document." 
 
Signature of Investigator______________________________________     
Date_____________ 
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Please select the best response 
 
Sex 
� Female 
� Male 
Family Size (including yourself) 
� 1 
� 2 
� 3 
� 4 or more 
 
Age 
� 0-18 
� 19-25 
� 26-35 
� 36-49 
� 50+ 
Family Income 
� $0 - $9,999 
� $10,000- $19,999 
� $20,000- $29,999 
� $30,000- $39,999 
� $40,000 + 
 
Ethnicity 
� White 
� Black 
� American Indian 
� Hispanic 
� Asian/ Pacific Islander 
� Others 
 
Client Type 
� Student Part-time 
� Student Full-time 
� Staff/Faculty Part-time 
� Staff/Faculty Full-time 
� Community member 
 
Marital Status 
� Single 
� Married 
� Divorced 
� Widowed 
� Living w/Significant Other 
Disability 
� Not Disabled 
� Physically Disabled 
� Developmentally Disabled 
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Shorter Psychotherapy and Counselling Evaluation (sPaCE) 
This questionnaire is about problems or difficulties that people may have. It is concerned with 
how you have felt in the last two weeks, including today. 
 
The statements below refer to problems or difficulties that may have distressed you over the last 
two weeks. Please read each statement carefully. Circle the number to the right that best indicates 
how much you have been bothered or distressed. For example, if ‘‘Finding it an effort to 
remember things’’ has distressed you ‘‘Quite a bit‘‘, circle 3. 
 
During the last two weeks, how much were you distressed by: 
 0 1 2 3 4 
 Not at 
all 
A little 
bit 
Moderat
ely 
Quite a 
bit 
Extrem
ely 
1. Finding it an effort to remember things 0 1 2 3 4 
2. Thoughts about killing myself 0 1 2 3 4 
3. Feeling anxious or nervous 0 1 2 3 4 
4. Feeling hopeless 0 1 2 3 4 
5. Having to avoid things because they frighten me 0 1 2 3 4 
6. Not being able to get going 0 1 2 3 4 
7. Finding it hard to concentrate 0 1 2 3 4 
8. Wanting to harm myself 0 1 2 3 4 
9. Panicky feelings 0 1 2 3 4 
10. Feeling worthless 0 1 2 3 4 
11. Feeling afraid to go out 0 1 2 3 4 
12. Feeling tired most of the time 0 1 2 3 4 
13. Feeling confused 0 1 2 3 4 
14. Impulses to cut or mutilate myself 0 1 2 3 4 
15. Feeling tense 0 1 2 3 4 
16. Feeling life is pointless 0 1 2 3 4 
17. Feeling anxious in crowds 0 1 2 3 4 
18. Having no energy 0 1 2 3 4 
19. Having difficulty making decisions 0 1 2 3 4 
@Jeremy E Halstead, 1990/2000 
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Outcome Questionnaire (OQ-45.2) 
Instructions: Looking back over the last week, including today, help us understand how you have been feeling. 
Read each item carefully and mark the box under the category which best describes your current situation. For this 
questionnaire, work is defined as employment, school, housework, volunteer work, and so forth. Please do not 
make any marks in the shaded areas. 
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1. I get along well with others.  
2. I tire quickly.  
3. I feel no interest in things.  
4. I feel stressed at work/school.  
5. I blame myself for things.  
6. I feel irritated.  
7. I feel unhappy in my marriage/significant relationship.  
8. I have thoughts of ending my life.  
9. I feel weak.  
10. I feel fearful.  
11. After having a drink, I need a drink the next morning to get going.  
      (If you do not drink mark “never”)  
12. I find my work/school satisfying.  
13. I am a happy person.  
14. I work/study too much.  
15. I feel worthless. 
16. I am concerned about family troubles.  
17. I have an unfulfilling sex life.  
18. I feel lonely.  
19. I have frequent arguments.  
20. I feel loved and wanted.  
21. I enjoy my spare time.  
22. I have difficulty concentrating.  
23. I feel hopeless about the future.  
24. I like myself.  
25. Disturbing thoughts come into my mind that I can’t get rid of.  
26. I feel annoyed by people who criticize my drinking (or drug use).  
     (If not applicable mark “never”)   
27. I have an upset stomach.  
28. I am not working/studying as well as I used to.  
29. My heart pounds too much.  
30. I have trouble getting along with friends and close acquaintances.  
31. I am satisfied with my life.  
32. I have trouble at work/school because of drinking or drug use.  
     (If not applicable, mark “never”)  
33. I feel that something bad is going to happen.  
34. I have sore muscles.  
35. I feel afraid of open spaces or driving or being on buses, subways and so forth.  
36. I feel nervous.  
37. I feel my love relationships are full and complete.  
38. I feel that I am not doing well at work/school.  
39. I have too many disagreements at work/school.  
40. I feel something is wrong with my mind.  
41. I have trouble falling asleep or staying asleep.  
42. I feel blue.  
43. I am satisfied with my relationships with others.  
44. I feel angry enough at work/school to do something I may regret.  
45. I have headaches. 
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